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PREFACE


TECHNICAL AND ECONOMIC FEASfBILITY OF SPACE BIOPROCESSING


WAS STUDIED WITH THE FOLLOWING CONCLUSIONS:


1. CURRENTLY SPACE BIOPROCESSING IS LIMITED TO ELECTRO-

PHORETIC SEPARATION OF CHARGED PARTICLES. THIS


PRACTICE CAN BE BROADENED TO PRODUCE ORGANIC MOLECULES


BY MEANS OF BIOSYNTHESIS AND RECOVER THEM WITH


SEPARATION TECHNIQUES, INCLUDING ELECTROPHORESIS.


WITH THIS APPROACH, A COMPLETE MANUFACTURING SCHEME


IS ACHIEVED WITH FULL CAPABILITY TO PRODUCE ORGANIC


COMPOUNDS OF SOCIAL IMPORTANCE UNDER MICROGRAVITY


CONDITIONS.


2. 	 ACCORDING TO THE AVAILABLE EXPERIMENTAL DATA, SPACE


ENVIRONMENT OFFERS ADVANTAGES OVER I-G CONDITIONS


IN HANDLING GASES AND LIQUIDS ESSENTIAL TO IMPROVE


BOTH BIOSYNTHESIS AND RECOVERY TECHNIQUES.


3. 	 AS A PREREQUISITE TO IMPLEMENT SPACE BIOSYNTHESIS IT


IS NECESSARY TO DETERMINE IN QUANTITATIVE TERMS THE


DIRECT OR INDIRECT EFFECTS OF MICROGRAVITY ON CELLULAR


AND SUBCELLULAR (ENZYMATIC) ACTIVITIES.


4. MODEL REACTIONS WHICH QUANTITATIVELY'DEFINE THESE EFFECTS


INVOLVE THE ENZYMATIC OR MICROBIAL TRANSFORMATION OF


GLUCOSE INTO GLUCO4C ACID. PROCESS MECHANISMS ARE


KNOWN AND THE KINETICS CAN BE FOLLOWED BY DIRECT READING


SENSORS,


5. 	 ORGANIC COMPOUNDS SELECTED AS PRIME CANDIDATES FOR


SPACE BIOPROCESSING ARE THE PEPTIDE (PROTEIN) HORMONES.


INCREASING SOCIAL NEED, HIGH COST OF PRODUCTION AND


BROADENING FIELD OF APPLICATION WARRANTS THE SELECTION.


6. 	 DESIGN AND OPERATION PRINCIPLES OF A COMPLETE BIO-

PROCESSING EQUIPMENT IS OUTLINED IN THIS REPORT.


THE 	 EQUIPMENT CONSISTS OF: 1)BIOREACTOR, 2)RE-

COVERY AND 3)AUXILIARY SUBSYSTEMS, INSTRUMENTATION


AND 	 CONSTRUCTION 0F BIOREACTOR MAKES IT POSSIBLE


TO PERFORM MODEL REACTIONS AND CULTURE ANIMAL CELLS


FOR THE PRODUCTION OF HORMONES. THE PRODUCT CAN BE


RECOVERED-PURIFIED WITH THE RECOVERY SUBSYSTEM.


7. A COMPREHENSIVE PROJECT TO INVESTIGATE EXPERIMENTALLY


THE POSSIBILITIES OF SPACE BIOPROCESSING IS OUTLINED.


THIS CONSISTS OF SYSTEMATIC STUDIES ON THE BIOSYNTHESIS


AND RECOVERY-PURIFICATION OF PEPTIDE-PROTEIN TYPE


HORMONES UNDER I-G AND 0-G CONDITIONS. THE MULTI-

DISCIPLINARY EFFORT UTILIZES THE SOUNDING ROCKET,


SPACE SHUTTLE AND SPACELAB FLIGHTS, ESTIMATED DURATION


OF THE PROJECT (STARTING IN 1977) is 5+YEARS.


8. 	 ANTICIPATED RESULTS INCLUDE:


1) 	 UNQUESTIONABLE DEFINITION OF EFFECT OF 0-G ON


CELLULAR AND SUBCELLULAR ACTIVITIES,


2) 	 DEVELOPMENT OF NOVEL PEPTIDE-PROTEIN BIOSYNTHESIS


AND RECOVERY TECHNIQUES,


3) 	 DEVELOPMENT OF SPACE BIOCHEMICAL ENGINEERING.


9. 	 ANTICIPATED SPINOFFS OF THE EXPERIMENTS INCLUDE:


1) 	 IMPROVED KNOWLEDGE ON CELL METABOLIC ACTIVITIES,


2". 	 ADAPTATION OF TECHNOLOGIES TO MANUFACTURE OTHER


PEPTIDE-PROTEIN TYPE COMPOUNDS OF SOCIAL IMPORTANCE


UNDER TERRESTRIAL AND/OR SPACE CONDITIONS,


3) ADAPTATION OF MEMBRANE SEPARATION TECHNOLOGIES TO 
ARTIFICIAL ORGAN APPLICATIONS, 
4) ADAPTATION OF DEVELOPED TECHNIQUES FOR TERRESTRIAL 
CHEMICAL OR BIOLOGICAL PROCESS CONTROL. 
5) APPLICATION OF KNOWLEDGE IN OTHER AREAS OF SPACE 
TECHNOLOGY (E.G. LIQUID WASTE TREATMENT IN SPACE 
COLONIES). 
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Lm'INTRODUCTION


In the past years there was an increasing interest


observable toward the biological aspects of the


space environment. So far, however, experiments
 

related to the life sciences were geared because


of obvious reasons - toward human physiology and


medicine.


The Colloquium on Bioprocessing in Space held at


NASA's Lyndon B. Johnson Space Center (Houston, TX)


reached an understanding on the importance of cellular


and subcellular systems oriented research in space.


Experiments related to cell biology (including propa­

gation of embryo cells, fungi, bacteria, bacteriophage,


viruses) resulted in predominantly qualitative


information relative to the effect of space environment


on cellular functions. However, various experimental


data with respect to behaviour of microorganisms


exposed to space environment indicate that this


unique condition may offer advantages in propagation


of cells and biosynthesis of organic compounds.


In addition, the advantages of zero-gravity on


separation of biological materials using electro­

phoresis (EFO) was demonstrated (1,2). This subject


was already discussed from a broader point of view


by BREDT and MONTGOMERY in 1975 (3).


Since electrophoresis has been widely used in process


biochemistry for long periods of time (4,5), its


successful application in space has opened up the
 

possibility to utilize both the enhanced metabolic
 

capability of living cells and the improved separation


technique to produce organic compounds of scientific


and medical importance in space.


Based on early successes with space electrophoresis


the term: space bioprocessing is currently used for


a process whereby charged particles are separated by


means of a physico-chemical technique.
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From the viewpoint of terrestrial biochemical engi­

neering bioprocessing means the production of organic


compounds via biosynthesis in a bioreactor(using intact


cells or their subcellular elements, e.g. enzymes


for this purpose) and separating them from the reaction


mixture by means of physicb-chemical techniques.


Using electrophoresis only to separate biological


materials in space, the following technological schedule


can be accomplished:


1. 	 Material is processed on Earth with conventional


techniques,


2. 	 Material-shuttled into microgravity environment


where it is separated, purified, etc.,


3. 	 Material is returned to Earth for further


processing with conventional techniques,


4. 	 Utilization of the material on Earth.


If a biochemical reactor is designed with a capability


to support cellular and subcellular activities under


zero-gravity conditions and this reactor is connected


to an EFO apparatus the result is a complete bio­

processing equipment which performs both biosynthesis


and 	 recovery functions in the microgravity environment.


Operating such equipment, the former technical scheme


is broadened incorporating the first three steps in


one 	 functional entity (system). Only the raw material


supply and the return of the finished product are


subjects of shuttle transportation. This scheme has


definite advantages from the viewpoint of logistics


and 	 ease of operation. A careful analysis is needed,


however, to define the technical advantages and the
 

potential social effects a space bioprocessing tech­

nology may create if it is implemented.
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Supported by a grant (NAS9-14961), Fermentation Design,


Inc. performed a study on this subject. The seven­

month search resulted in the compilation of the


available information relative to the following areas:


1. 	 Which biological processes can be used as models


to define quantitatively the effect of space


environment on metabolic activities of cells
 

and 	 enzymes,


2. 	 What is the organic compound of choice, bio­

processing of which is economically attractive


if the model experiments demonstrate enhanced


metabolic activities in the space environment,


3. 	 What kind of equipment is necessary to carry


out biosynthesis oriented research and develop­

ment in the space and perform control experiments


on the earth, and finally:


4. 	 What problems in industrial cell culture systems


are gravity related and what potential solutions.


can be offered by culturing cells in microgravity


environment.


Additional scope of the survey was the compilation


of available technical and scientific information.


This serves as the basis to design experiments to:


1. 	 Check the performance capability of the biopro­

cessing system designed and built for cell
 

cultures, product biosynthesis and recovery, and


2. 	 Test the effectiveness of the selected technology
 

which will be developed during the project


implementation.


The 	 survey revealed that:


1. 	 There is a possibility to test the effect of micro­

gravity on cellular and subcellular activities,
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2. 'Viewing the tendency of the microbiology based


industries it is possible to find economically


significant organic compounds which may be
 

candidates for bioprocessing in microgravity,-and


3. 	 It is possible to design an apparatus which can


be considered as a prototype of a "bioprocessor"


which can be used both for test purposes and


initial studies of bioprocess organic compounds


of significance in the space.


Conclusion and recommendation part of the survey


compiles these key points and serves as an executive


summary. Therefore, scientific studies can be bypassed


if the reader is not interested in technical details.
 

It is hoped that the information compiled in this


Final Report will give an impetus to the effort


NASA is currently making to exploit the advantages


of space environment in processing biological


materials using novel.technologies in the field of


biochemistry, cell cultures and separation processes.


2. 	 OBJECTIVES


In view of the developments in biochemical engineering,


applied biochemistry and considering the trends in the


pharmaceutical industry, the objectives of this study


were:


1. 	 Finding a reaction mechanism by which quantitative


studies can be performed,-unequivocally demonstrating


the effect of space environment on organic chemical,


enzymatic and cellular reactions. This mechanism


can also serve later as a quality control procedure


to check the performance characteristics of


equipment designed for the project implementation;
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2. Finding a product line of social significance


which can be a candidate for industrial scale


bioprocessing in microgravity environment;


3. 	 Outline the design principles of an apparatus


by which test experiments can be performed both


to check quantitatively the advantages of


microgravity conditions on cellular activities


and enzymatic reactions, industrial bioengineering,


and perform studies on the production character­

istics of the organic compound(s) found suitable


for bioprocessing in space;


4. What necessary steps are required to implement


-	 the project as well as the minimum success 
criteria for each step. 
Methodology of the survey included collection-of
 

scientific-technical data in order to support our


position, draw conclusions and make recommendations


in the subject matter.


3, LITERATURE REVIEW


3.1. GENERAL COMMENTS


This part of the study is considered essential to


conclude the prior art as well as to define relevancy


of biological experiments performed in a space environ­

ment. The search of the literature revealed that 1)


papers, documents written on the subject are not readily


accessible, most of them being internal reports of


companies, research institutions or their consultants


-as well as being contract reports, 2) because of the
 

lack of experimental information, most of the essays


are speculative, 3) conditions of the experiments are


generally inadequate in view of the complexity of


living systems and 4) there is an "identity problem"


resulting in confusion of terminologies calling the
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discipline involved "space bioprocessing", "space


microbiology", "space biotechnology", etc. All of


these described features are generally characteristic
 

to newly evolving disciplines. It is desirable, there­

fore, to try to find common denominators, define te'rmin­

ologies and make them widely accessible to the industrial


and scientific community in the near future.
 

Review of the available literature made it possible


to categorize the documents into two broad classes,


namely:


(1) 	 Description of effect of space environment on


microbial systems.


(2) 	 Concepts and accomplishments in equipment


design and operation.


Of course, in many cases the two classes appear in


the same literature. At this stage of the work,


however, it seems necessary to evaluate the two


classes separately.


3.2, 	 PHYSICAL BEHAVIOUR OF MATERIAL AS A EACTOR INFLUENCINi
 

BIOOGICAL PROCESSES IN THE SPACE


The survey revealed a series of problem areas all of


them of importance from technical and logistics points


of view. Biosynthesis processes are performed in


*aqueous systems and are controlled predominantly by


mass transfer conditions (6). -This is emphasized in


the case of transfer of gaseous materials into and


out of the liquid. In particular, because of its


low solubility, the transfer of oxygen into the


liquid is rated among the key-problem areas.


In addition, the removal of "metabolic heat" is


considered as an other technical problem in unit
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operations. Under 1-G conditions these problems


are technically solved (although not to complete


satisfaction) by application of mixing elements


and aerators to the bioreactors.


During the review of literature related to the


physical behaviour of liquids in Space, unusual


characteristics were revealed - lack of convection,


buoyancy (3)-. This is of extreme importance with


respect to mixing of three phases (gas, liquid,


-solids (cells)) in order to accomplish the mass and


heat transfer conditions necessary to carry out


biosynthetic activity on cellular and/or subcellular


level. There are no literature data available -on


the effect of liquid physico-chemistry- upon metabolism,


which necessitates intensive study in this field.


The second area of importance is the statistical


accuracy of the presently available data on the
 

behaviour of cellular and subcellular systems exposed


to space environment conditions. Data available were


primarily of a qualitative nature. Therefore, it is


absolutely necessary to obtain data of high statistical


accuracy in order to define the effect of space


environment on metabolic activities. This requires


kinetic studies not only on cellular and subcellular


level but, if it is possible, on the level of organic­

chemical synthesis. This latter area of activity is


considered essential to define the influence of


unusual fluid behaviour on reaction kinetics with


the interaction of cellular-subcellular elements.


Third, since all of the experiments will ultimately


be conducted in a habitat (Spacelab) where the work­

load is high, the maximum possible level of automation


is to be considered for 1) to follow the process and


2) coordinate the function of individual system elements.
 

The prototype's operation may result in technical


information essential to construct fully automated


bioprocessing systems in the Space.


Fourth, substantial amount of experimental work is


needed on the Earth before attempts to perform


biosynthesis in Space can take place. The work must


be geared to develop equipment and test procedures


for a biosynthesis system in order to compare the


results obtained on Earth and in Space.


3.3. EFFECT OF SPACE ENVIRONMENT ON UNICELLULAR LIVING SYSTEMS


Space environment has four unique factors influential


on living systems: 1) ultralow temperature, 2) high


vacuum, 3) high energy particle (radiation) effects,


and 4) weightlessness (or low gravitational acceler­

ation). Considering these effects, factors 1) and 2)


will possibly be excluded from the future biosynthesis


systems by proper design whereas factors 3) and 4) are


anticipated to be utilized in the cellular genetics


and physiology. In particular, factor 4) (O-G
 

condition) is considered to be the most important,


reportedly influencing cellular metabolic activities.


Also, factors l)-3) can be reproduced on the Earth.


On the other hand; zero-gravity, consequently zero­

gravity based technology does not exist under terr­

estrial conditions. It is anticipated, therefore,


that the bioprocessing technology development will


mainly be based on utilization of weightlessness as


key-environmental factor.


So far, the most concise review on the behaviour of


micro-organisms in Space was given by TAYLOR (7).
 

Based on his and other authors' reports, the


following analysis can be made on the effect of


varipus space environmental factors on unicellular


living systems.
 

3,3,1, EFFECT OF UV RADIATION AND SPACE VACUUM.


Although solar ultraviolet irradiation in the wave­

length between 200 and 300 nm inactivated T-l


coliphage, P. roqueforti and Tobacco Mosaic Virus


(LORENZ et al, (8)), effects below 200 nm and above


300 nm (up to 5,000 nm) were not significant. This


finding is similar to those observed on Earth


with UV lights.


Other data obtained with ten microbial strains


exposed to both solar UV and space vacuum indicate


that the space vacuum may enhance the susceptibility


of spores to UV rays (at 254 nm) (7). On the other


hand, B. subtilis strain 168 spores survived space


vacuum (and low temperature although this latter


condition is not mentioned as the objective of the


experiment when they were shielded against the UV rays.


Solar UV rays on Aeronomas proteolytica, Rhodotorula


rubra, S. cerevisiae, Trychophyton terrestre,


Chaetomium globosum (Apollo 16) did not alter signifi­

cantly the survival rate or endopeptidase production by


(A. proteolytica) (7).


3,3,2, EFFECT OF HIGH ENERGY PARTICLES


The subject was investigated as part of an-analysis of the


mutagenic effect of heavy irradiation on microbial


cells. Probably the best planned experiment was


performed by BUCHNER and his coworkers (9, 10),


followed by an evaluation made by HORNECK et al (11).


B.subtilis strain 168 spores were imbedded in thin


sheets of PVA layers containing dosimeters for


meAsuring the passage of high-energy, multi-charged


(HZE) particles. Comparing the experimental data


with controls performed on the Earth it appears


that HZE particles had no effect on subsequent


germination and outgrow of spores. Although genetic


evaluation was not made, the experiment, at least,


indicated that spores which were hit by HZE particles


in space retained their ability to germinate.
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ZHUKOV-VEREZHNIKOV and his coworkers utilized B.


coli K-12 (A) phage to test the amount of Y-radiation


as well as the protons and rapid neutrons ( 12).


Experimental system exposed for 2-25 hours to space


conditions resulted in increased phage production


(compared to Earth control conditions) and the
 

phage production increased (although not propor­

tionally) with the duration of the flight.


Control experiments also indicated that vibration


during launch followed by Y-radiation may create


this-phenomenon.' On the other hand, MATTONI (13)


as well as MATTONI and coworkers reported (14)


experiments with S. typhimurium where the phage


production decreased (as a result of increased


resistance of S. typhimurium against Y-radiation).


Later, ZHUKOV-VEREZHNIKOV and his coworkers also


reported decrease-in phage production by E. coli (15).


Experimental results with Neurospora crassa (Conidia)


during the Gemini XI and Biosatellite II flights


indicate that neither the survival nor the mutation


frequency of the conidia deposited on surfaces


were altered during 71 hours orbital, flight (14).


Conidia suspended in agar expressed high levels of


survival and lower frequency of mutation induction.


On this basis, SERRES et-al concluded that the


spaceflight affected a protective influence (16).

Experimental data were, however, biased because of


the uncontrolled high temperature inside the space­

craft.


3.3,.3, EFFECT OF WEIGHTLESSNESS


One of the objectives of the Biosatellite II project


was to evaluate the effect of weightlessness on 1) 
bacterial growth, 2) free.bacteriophage density, 3)


phage induction and production rate and 4) bacterial


ultrastructure.


The most significant observation was that S.


typhimurium cell density was significantly-higher


than the one obtained in the ground control experi­

ments (13). No other measured variables differed


significantly from the control state; MATTONI's"


interpreEation of the increased cell density is


centered around the random celi distribution in the


culture liquid under reduced gravity conditions.
 

Such a distribution would increase the efficiency of


nutrient transfer into and waste transport from the


cells. JORDAN's interpretation of the phenomenon (17)


calls for the unknown physico-chemical (lack of


buoyancy) and environmental factors influencing


sedimentation of bacteria, liquid mixing (hence 02


supply) as well as foaming. Behaviour of fluids


under weightlessness (18) seems to corroborate this


concept. Also MATTONI mentions (13) that in unicell­

ular systems the direct effect of weightlessness on


intracellular mechanisms is less probable than the


indirect-ones (through the unusual fluid-gas mixing


conditions). As CUTAIA concludes, "the observation


is a result of many factors ... and leaves the


question of the specific impact of weightlessness


unanswered." (19).


3,4, EQUIPMENT DESIGN CONCEPTS AND ACCOMPLISHMENTS 
Above mentioned in-flight experiments were carried


out in test tubes, on agar plates,or on membrane


surfaces. The equipment used for-these projects


did not leave provision to measure and/or control


environmental conditions (e.g. temperature) or to


follow the growth patterns.


The first known experimental apparatus which had the


provision to insulate the growth-chamber from the


rest of the orbital-vehicle is reported by WARD and


his coworkers (20). The equipment mas used to test


the physiological behaviour of multicellular algae
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(Chlorella sorokiniana), and duckweed (Spirodella


polyrhiza) during the orbital flight of a non­

recoverable orbital vehicle (OVI) sponsored by the


Air Force Office Of Aerospace Research (AFOAR).


The apparatus contained a growth chamber with airvents,


temperature and pressure control, 02 and C02 sensors,


illumination and light sensitivity measuring apparatus


to assure 12 hours of light-dark periods for the


photosynthetic organisms.- The equipment was sterilizable.


Sensed variables were.collected on magnetic tapes and


sent back to the Earth by telemetry when the satellite


was over a tracking station.


The reports prepared by the experimenters revealed


that 1) despite the complexity of the system sterile


culture was obtained using heat, ethylene oxide-C02


sterilization of the apparatus as well as UV illumi­

nation during the transfer of the cultures, 2)


temperature control within 27.4 to 28.10 C was achieved


(t 0.350 C), 3) pressure increased from 751.1 to


764.5 mmGh in 228 hours (dP/dt = +0.057 mmGh/hr),


4) illumination control system worked satisfactorily,
 

5) signal transmission was 87.5 percent effective


(three out of 24 data points were lost), 6) one of


the two apparatus developed leak and lost pressure


following the launch resulting in a complete loss of


the Ch. sorokiniana experiment.


Further analysis of the experimental setup revealed
 

that besides the proper function of the apparatus,


there were two sensitive areas of the test, namely:


1) preflight maintenance of environmental conditions


for growth (the cultures stayed in launch position


for 255 hours) and 2) physical stresses due to the


launch. In the case of the slow-growing duckweed,


the first problem is not serious compared to the


conditions existing in the case of a fast-growing


microbe.
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The experiment was performed on a 547.03-478.73


nautical miles orbit and the gravitational force was­

5
1.1 x 10- g on the cultures. The RQ value (light


period RQ) was 1.0 at flight versus 0.9 on ground


control, the RQ (dark RQ) was 0.9 during flight versus


1.3 on ground which was considered insignificant by


the experimenters (22). Based on our experiments


with CCFS which measured RQ by DAN program (21) such


difference may originate from instrument inaccuracies.


Another apparatus for production of vaccines in zero­

gravity is proposed by-JORDAN of Martin Marietta Co.


(17). Equipment (designated as "zero-g-fermentor")


is based in fact, on a dialysis fermentor designed


by SCHULTZ and GERHART (22) where the culture is


circulated through a dialysis membrane in order to


assure fluid mixing (hence 02 transfer) as well as


to remove undesired products of inhibitory nature


(e'g. C02). It is not known, however, whether a


prototype was built and experimentally tried.


Therefore, the equipment performance to establish and


maintain proper environmental conditions (T, P, pH,


DO, substrates' concentration and proportion) cannot


be evaluated. Nevertheless, the concept may serve


as the starting point to design bioreactors for ex­

tended study of the effect of space environment on
 

microbial cell physiology and metabolic activity. It


is noted that MMC has a patent pending "Apparatus and


Method for Microbial Fermentation in Zero-Gravity


Environment" (Serial 143808, May 17, 1971).


3.5. BIOPROCESSING IN SPACE


Parallel with the biology-orientedexperiments, NASA


performed extensive studies on material processing
 

in space. A concise study appeared on the results


(3) as well as a Colloquium was held at NASA's Johnson


Space Center in March, 1976. Information indicates


that electrophoresis (EFO), a widely used technique


for separation of organic dompounds in biochemistry
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and biotechnology, can be useful tool in space bio­

processing because it gives finer resolution and


separation of charged particles (including living


animal cells) than EFO performed under l-G conditions.


These results necessarily lead to the development of


a bioprocessing system (23) which incorporates both


the biosynthesis and recovery techniques and apparatus.


The complexity of such an operation requires high


level instrumentation for analysis of process status


and 	 process control as well as the coordinated function


of the auxiliary equipment. This integrated system


concept is considered as an advanced form of equip­

ment and technology for automatic and Pomplete


bioprocessing operations in space.


3.6, ASSESSMENT OF RESULTS 
Althoughthe reported results are in many cases con­

tradictory (by virtue of the difficulty to separate


the 	 antagonistic and/or synergistic effects of various


space environmental factors on cellular physiology)


data indicate that:


1. 	 Spaceflight environment can be selective creating


cellular behaviour different from the Ones found


on Earth.


2. 	 It isnecessary to design a test method comprising


a series of experiments-which ultimately prove


or disprove this selectivity both from qualita­

tive and quantitative points of view.


3. The test method must be concise enough to cover


activities on extracellular, cellular, and sub­

cellular level.


4. 	 The experiments must be conducted in well-controlled


environment to rule out the interactive effects


of various environmental factors, and finally,
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5. 	 An integrated system must be designed to implement


bioprocessing in the Space.


In conclusion, it became evident that two parallel


operations have to be considered, namely:


1. 	 Development of a test method to achieve unequivocal


answers on the effect of space conditions (weight­

lessness in particular) on extracellular, cellular,


subcellular kinetics (initial stage of operation),


and


2. Definition of a compound, bioprocessing-of which


in Space has scientific, economic and/or social"


importance.


The equipment to be designed for this purpose must


have specifications which make it possible to apply


it to both types of operation.


4, MODEL REACTIONS FOR SPACE BIOPROCESSING EXPERIMENTS


4,1, GENERAL CONSIDERATIONS


A major objective for the initial stage of the Bio­

processing Program is the demonstration of technical


feasibility of space biosynthesis and biochemical


separation techniques. Implementation of biosyntheses


and recovery-purification processes in Space, however,


faces-constraints from the viewpoint-of payload, in


particular regarding the requirement of a relatively


large quantity of water during each step of the operation.


Among other important constraints are the maintenance


of aseptic conditions during the culture and product


recovery as well as the automatic operations.


Usefulness of bioprocessing can .be demonstrated in


production of one or more organic compounds of high


scientific or medical value in a quantity applicable


on Earth'for at least experimental purposes.
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In an attempt to define the most promising materials,


Table I lists various organic compounds produced at


I-G by means of biosynthesis and physicp-chemical


recovery techniques on laboratory or industrial scale.


Each process represents a type of metabolic pattern


and has attractive features from experimental point


of view.


Accordingly,


1. 	 Production of cell mass (SCP) or ETOH on carbo­

hydrates can be the subject of experiments of


shifting metabolic pathway in favor of one product


accumulation (NYIRI-and KRISHNASWAMI) (24).


2. 	 Biosynthesis of gluconic acid from glucose is a


classical example of combined and staged activity


of various cell-bound, cell-free enzyme systems


as well as nonenzymatic conversion of an inter­

:mediate into final product. The process pathway


is defined, therefore, comparative studies based


on stoichiometry can be performed.


3. 	 Production of oxytetracycline (OTC) has the com­

bined characteristics of the former two processes


(with the exception .of nonenzymatic catalysis


istep). In addition, the problem of contamination


*is greatly reduced because of the wide spectrum


of the antibiotic activity.
 

4. 	 Biosynthesis of vitamin B12 is an example of


mixed culture operation incorporating complex


growth and product formation kinetics.


5. 	 Hormone production by animal cells (tissues).


The process and its technology is currently


under development.


As it is noted on Table I, with the exception of the
 

first process, product recovery can be implemented


either by chromatography or by electrophoresis.


ANALYSIS OF PROCESSES FOR SPACE BIOTECHNOLOGY


PRODUCT PROCESS MAIN PRODUCTS TYPE OF 	 VALUE(A) ANNUAL (v


PRIMARY SECONDARY RECOVERY 	 REQUIRE'ENT 

(CELLS) #1 #2 #1 #2 (ESTD) 

(CRUDE) (PURIFIED) 

1. 	SCP/ETOH C.UTILIS 25 G/L ETOH80 G/L FILTR, DIST. 1,9x10-3 30x10-3 106T 

SUBMERGED 

2. GLUCONATE P.OVALIS 3 G/L GA:40 G/L FILTR. CHROM. NIL 1.9x10 0
1 T 

SUBMERGED 	 DIAL, 

3, OXYTETRA- SRIMosus 8 G/L OTC:30 G/L FILTR. CHROM, NIL 2.5 103­

CYCLINE SUBMERGED DIAL, EFO 

4, VITAMINE MIXED CUL-
TURE 
6 G/L B :0,3 G/L
12 
FILTR, 
DIAL. 
EFO FEED 4,7 102T 
SUBMERGED 
5. 
HORMONES 
THYROTROPH
MAMMOTROPH 
109CELLS/L GH:0.5 G/L DIAL. EFO ? lxo 3 0.1 T 
CELLS 
(A) PRODUCT VALUE ESTIMATED FOR PROCESSING ONE LITER CULTURE LIQUID WITH A RECOVERY Loss OF 25'.


(B) ESTIMATED POTENTIAL NEED IN'USA.


=
NOTE: ESTIMATED VALUES ARE GIVEN: 1 $US/L(KG)s 2= $US/100G; 3= $US/KG; 4= $US/KG; 5 SUS/G"


On the other hand, the absolute (scientific, commercial)
 

value of products #1-#4 is low, whereas the desired


quantity for application is relatively large. Even


in the case of substantial improvement in biosynthesis


(assuming fourfold increase in space) the needs can


be fulfilled only with moving of large quantities


of water.


Because of these considerations, any of the processes


has short range of applicability and scientific value


and-can be used only in the testing stage of space


biosynthesis and recovery equipment.


Product #5 has the advantage of experimental trial


of eucaryote cell growth exposed to space environment


as well as production of compounds of scientific and


medical significance. In particular, production of
 

certain hormones such as hormones from glands located


in the brain (hypothalamus, pituitary gland), adrenal


cortex, etc., may be listed here as prime candidates.


In addition, electrophoresis is considered as the
 

best means in separation of the protein and poly­

peptide compounds from the culture medium components


(e.g. from serum). POSNER, in a short discussion (25)


describes the most recent achievements (notably, direct


relationship between cell mass and GH production,


suspension culture of pituitary tumor cells, enhancing


effect of hydrocortisone on GH production, release


of hormones into extracellular liquid). With a po­

tential increase of cell density to 1012 cells per


liter from 109 cells per liter, gonadotropin hormone


production can be substantially augmented ( a
 

cautious estimation is a fourfold increase in GH pro­

duction). WIMMELFARB and his coworkers already


reported 10 cells per ml in a perfusion-suspension


apparatus (26).


Because of the complexity of hormone production, this


process, however, can not serve as test method to


obtain unquestionable answers on the effects of space


environment on cellular and subcellular mechanisms.
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42 MODEL REACTIONS FOR KINETIC STUDIES


Considering the above mentioned facts and problems,


basic research is necessary to answer the following


fundamental questions:


1. 	 Does a space environment provide better, identical


or inferior conditions for chemical or biochemical


reactions at the cellular level?,


2. 	 Does a space environment affect the quality of


the material obtained as a result of metabolic


activity of cells?


3. 	 As a conclusion of the series of tests: What


manipulative advantage (fluid handling, diffusion


controlled convection) appears most'promising to


perform biosynthesis and product recovery-purification
 

in Space?-

These questions are yet to be answered implementing


well-planned and concise experiments resulting in


statistically consistent data. This fundamental step


in research is considered as a prerequisite for


establishing a space bioprocessing program which has


scientific and commercial significance.


Relative to the previous questions, the first question

deals with the most fundamental problem area of


material processing: reaction kinetics (the quanti­

tative aspect of the process). The second question


is related to studies on higher levels of cellular


organization including concerted operation of several


enzyme systems, their biosynthesis, and the effect


of a space environment on cellular genetics (quali­

tative aspect of the process).


Accordingly, objectives of the experiments are:


1. 	 Determination, within the limits of statistical


accuracy, the characteristics and the direct


or indirect effect of microgravity on selected


biological reactions.
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2. 	 Developing techniques by which performance char­

acteristics of space biosynthesis systems can


be evaluated.


In 	 order to meet these objectives, it is necessary:


1. 	 To find a compound of biological significance


which can be formed by 1) organic chemical syn­

thesis (at least molecular rearrangement), 2)


enzymatic catalysis involving no more than two


enzymes, 3) direct biological activity of intact


cells 	 where 4) the product is extracellular


(therefore can be removed by dialysis).


2. 	 The concentration of substrate, intermediate and/


-or.product, can be monitored by at-least one


process sensor signal which reflects the reaction


kinetics (without quenching or sampling the


reaction mixture for wet chemical analysis).


3. 	 The reaction must be fast enough to cope with


the limited time available in microgravity during


the Sounding Rocket Flights (if the operational


test of equipment is performed by this means),


but the time length of the reaction can be ex­

tended by the increase of reactants' concentrations


for Space Shuttle Flights as well as for Spacelab


experiments.


4. 	 The reaction kinetics must be well-documented in


1-G gravity to serve the purpose of comparison.


5. 	 The reactants can not have toxic, flammable or


otherwise hazardous characteristics.


6. 	 The reaction must be conducted with high precision


in relatively small volumes to meet the payload


requirements of the Sounding Rocket Programs (as


a minimum requirement), but also be capable of


scale-up for future Space Shuttle and Spacelab


experiments or, even up to larger scales.
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These objectives initiated a search to find a parti­

cular reaction. Numerous attractive biological


systems were considered and rejected because of


failing to meet one or more requirements. Both the


model reactions listed in Table I and those proposed


by other researchers (19) were evaluated. Evaluation


patterns are listed in Table II, concluding that


glucose-gluconic acid conversion is a candidate


which meets criteria set forth. Therefore, we pro­

pose the glucose-gluconic acid conversion as a model


system for the purpose of:


1. 	 Kinetic studies conducted under both 1-G and


O-G conditions to accurately determine the


differences between the product formation rates


and the absolute yield if the reaction is con­

ducted in an essentially different environment.
 

2. 	 Testing the bioprocessing system's performance


from the viewpoints of capability 1) to help


to synthetise and 2) to recover-purify organic


compound as well as to perform automatic opera­

tions on the basis of on-line, real time acquired


signals describing the process status.


This second purpose can be used to test the performance


of all the prototypes developed during the experimental


period.


GLUCONIC ACID (GA) PRODUCTION


CHEMICAL CHARACTERISTICS OF GA


Gluconic acid (synonyms: dextronic acid, maltonic


acid, glyconic acid, glycogenic acid) is pentahy­

droxycaproic acid with the following formula (I):


(C6H1207 ).


REACTION MET FAILED TO MEET


REQUIREMENTS REQUIREMENTS


B. SUBTILIS SPORES + ALANINE--SPORE GERMINATION 4,5 1,2,3,6,


LACTOSE + E. COLI- -* -GALACTOSIDASE 4,5,6 1,2,3, 
GLUCOSE + 0 + YEAST-----ETHYLALCOHOL 4, 1,2,3,5,6
2 
GLUCOSE + BACTERIA - GLUCONIC ACID 1,2,3,4,5,6


AMP + 2(P ) + ENERGY- ATP 1.1,1.2,1,3, 1,4,

1 5,6,


GLUCOSE CELLS, ENZYMES, ORG. CHEM, GLUCONIC ACID 1-6


G L U C O E G L C O ~ i A C I -1 ­
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COOH 
H - C - OH 
HO - C - H 
H - C - OH 
H - C - OH 
CH2oH


(I)


Main chemical characteristics are given as follows: 
- MW = 196.16, 
FORM = CRYSTALS (although difficult to crystallize), 
MP = 1310 C, 
K 25 x 10-4 (at 250 C in H20), 
COMPOSITION: C : 36.74%, H : 6.17%, 0 57.10%, 
)PTICAL CHARACTERISTICS: ( a) = 1), 
OLUBILITY: Freely soluble in water, 
Slightly soluble in ETOH, 
Insoluble: ether, 
ZYSTALLIZATION: Difficult,


)RROSIVITY: Corrosive against iron. Noncorrosive


against stainless steel (316 SS),


OXICITY: None reported.


ORMATION OF GLUCONIC ACID


\ccording to the literature (27), gluconic acid can


De formed essentially in four ways:


1) By ionizing radiation of D-glucose, 
2) Chemical synthesis from D-glucose, 
3) Enzymatic conversion of D-glucose to-glucono­
lactone which spontaneously hydrolyzes into 
gluconic acid, 
4) Microbial conversion from D-glucose. 
In all cases D-glucose is the starting material.


EFFECT OF IONIZING RADIATION ON D-GLUCOSE-

This subject is of particular importance because since


the ionizing radiation existing in Space may create


side reactions which interfere with the interpretations


of the experimental data.


According to PHILLIPS et al (28), when aqueous solution


of D-glucose was irradiated with electrons generated
 

by a van de Graff Generator (iMv) at 1 A'for-i hour


(energy input rate z 3.75 x 1020 ev/min) or with Y­

rays (2.13 x 1017 ev/min - 3.65 x 1016 ev/min), D­

glucose degraded to various compounds which may further


react to give secondary products. Figure I shows the


scheme of the degradation, whereas Table 3 presents


ORmA PAGE IS 
OF POOR QUALITY 
D-GLUCOSE


D-GLUCURONIC D-GLUCONIC D-ERYTHROSE GLYCERALDEHYDE 
ACID ACID + 
+ GLYOXAL 
02 
DIHYDROXYACETONE 
GLYCOLLALDEHYDE


+ 
D-ARABINOSE GLYOXAL


+ 
Co2


FIGURE 1


-SCHEME OF D-GLUCOSE DECOMPOSITION DURING


Y-IRRADIATION


(28)


26 
- Products when aqueous solution of D-glucose is irradiateduv-ih gamma-. 

radialionin oxygen. 
(a) Initial glucose, 7-8 mmoles. Energy input. 4.6 x 10"1 ev (volume 150 nii), 
Formalde­ n-Gluconic D-Glucur- Saccharic 
Product: n-Glucose D-Ervthrose Glyoxal hyde acid onic acid acid 
Carrier (mmole) 0.57 0.011 1-5 0.113 0-38 0.47 0-36 
Sp. activity (,C 
per mmole) ... 4-1 
Fracio­ -.........Neutral 
Yield (ramole)... 4.6 
344 
Neutral 
0-05 * 
0.0 
Neutral 
0-64 
0-012 
Distillate 
0.005 
2-8 
Acid 
024 
0-71 
Neutral 
0-45 
0-03 
Neutral 
0-012 
Corrected yield of gLucose in whole irradiated solution ............ .........52 mmoles
Corrected yield of glucuronic acid in whole irradiated solution ........................
0-50 mmole 
D-Arabinose estimated lrom paper chromatography ....................................0 30 mmole 
Confirmed by estimation from paper chromatogram. 
t e
(b) Initial glucose. 55 mmoles. Energy input. 32.6 x l0 v (1'o0ume 115 miL). 
Fornalde- D-'Gluconic r-Glucuronic 
Product: D-Glucose D-Erythrose Glyoxal hyde acid acid 
Carrier (mtole) 1-7 0-40 1-26 0.113 1.20 0-47 
Sp. activity (pc 
per mmole) ... 0 483 0-77 0-49 0 053 0-50" 0-92
Yield (mnmole) .. 1-13 0-22 0-96 0-147 0'63 -1-01 
D-Arabinose estimated from paper chromatogram, 0-6 mmole. 
(c) Initial glucose, 11.07 mmo'es. Energy input, 5-S x 1021 ev (volu,me 100 ml.). 
Formalde- . D-Gluconic D-GlucuronicProduct: D-Glucose n-Er-throse Glyoxal hyde avid acid 
Carrier (mmole) 1-37 0-68 1-13 0113 0-52 1-04 
Sp. activity (pC 
per mmole) ... 0-95 0-024 0.006 0-02 0-44 0-.35 
Yield (mmole) .. 7-05 0-09 0-5 0-05 0 44 0"60


D-Arabinose Saccharic acid v-Xylose Dilh droxvacetone 
Carrier (mmole) ..................1-04 0.35 1-88 1-19Sp. activity (pc per mmole)... o r90 6-8 .x l0-a 7-69 N 10" 0-068 
Yield (mmole) .................0-45 0-016 0.00 0-31 
TABLE III 
PRODUCTS ORIGINATED FROM D-GLUCOSE AFTER


-v- IRRADIATION 
(28)
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the concentrations -of the primary and secondary pro­

ducts. Although the detailed nature of the complex


process is yet to be investigated, authors postulate


that formation of D-glucuronic acid involved oxidation


of the CH2OH group while that of D-gluconic acid


entails ring scission, and the former reaction


appears to be favoured on the basis of the observed


yields. D-Arabinose is probably formed from gluconic


acid as a result of the secondary process involving


OH radicals. A small amount of D-xylose doubtless


arises from decarboxylation of glucuronic acid,


though it does not appear to be the main secondary


product arising from this acid. Similarly, the low


yield of saccharic acid suggests that this is not


the next stage in the oxidation of the gluconic and


glucuronic acid. Another important primary de­

gradation process is the formation of glyoxal by


the initial cleavage between positions 2 and 3, and


subsequently further contribution from other parts


of the molecule. D-Erythrose, which is probably


formed simultaneously with glyoxal is degraded ex­

tensively after its formation as indicated by its


low yield. This may be a complex process, and may


possibly involve the formation of further two-carbon


fragments or D-glyceraldehyde. The main concentration­

of this product, however, arises from a primary break­

down of the hexose into two triose molecules. This


is substantiated by the fact that dihydroxyacetone


is formed immediately at low doses owing to the


ready isomerisation of D-glyceraldehyde.


It is interesting to note that the yield of acid and


pattern of degradation were not influenced by the


glucose concentration (at least in the investigated


range) and the dose rate as well as the presence of


oxygen. This latter phenomenon and the postirradi­

ation appearance of the H202 plus H2 , CO, CO2 gases


hint that the chemical reactions'are initiated by


free radicals formed. GRANT and WARD (23) who per­

eormed irradiation experiments with D-glucose (also


ORIGINAL PAGWa 
OF, POOR QUALYf, 
n aqueous solution) in vacuum, using Co 60 Y­

rradiation (3.8 x 1016 ev/min) for 14 hours confirmed


he former observations and added to the list of


ompounds (Figure 1) 2-oxo7D-arabino-hexonic acid


.nd 2-oxo-D-arabino-aldohexose. The prolonged


.rradiation also indicated that gluconic acid is


.ormed in the early stage of the irradiation and


:hen undergoes an oxidative decarboxylation to yield


-arabinose + CO2. ,

In addition to the significance of these findings


iith respect to the statistical accuracy of a


)iochemical-microbiological experiment in Space,


Ehe described experimental results draw our attention
 

to the importance of analytical techniques. (spectros­

:opy, electrophoresis, chromatography, potentiometric


titration) by which products of such side reactions


must be investigated.


CHEMICALLY CATALYSED FORMATION OF D-GLUCONIC ACID


Using D-glucose as starting material four processes


were uncovered, all of them oxidizing S yielding D


gluconic acid (Figure 2).


1. 	 Process patented by STOLL and KUSSMAUL (30) is


based on former observations indicating that


aldoses e.g. glucose can be oxydi~ed to the
 

respective monocarboxylic acid (e.g. gluconic


acid) with hypobromite or hypoiodite. The


process calls for D-glucose as substrate (240


G/1,000 ml distilled water) into which 123.2 G/L


Ca(OH2) and 14 G/L NaBr is added. This mixture


is then treated with 38 G/L chlorine gas which


is cooled down (to an unspecified temperature,


probably to +150 C). Reaction ends with the


indication of disappearance of the oxydizing


agent. Ca(OH) 2 can be substituted with Mg(OH) 2


and NaBr with hypoiodite. During the oxidation,
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,-GLucosE,
T 
1 , Br* + H2O +BaCa 
Ca(OH) 2 + HCI04 + Br'BI ) 03 
2I 
Mg(OH) 2 +Br*(r) + I 
ELECTROLYSIS o - GLUCONO- D-LACTONE 
_13 -GLUCONO - D-LACTONE 
Br+ SATURATED


27N H 2SO 4 i 
 4 
D-GLUCONIC ACID-
FIGURE 2.
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intermediates probably appear, however, this


aspect is not covered in the description.


2. 	 Process described by HELWIG (31) improves the


aforementioned technique by using electrolysis
 

to facilitate the D-glucose - gluconic acid


conversion. The technique calls for 200 G/L


glucose, 20 G/L KI and 45 G/L Ca(OH)2 or Na2CO 3


using water as solvent which are placed in a


copper cup serving as cathode. A rotating graphite


anode is then used with a current intensity of


75 A/m2 at 10-15o C. The process claims easier


recovery of Ca-gluconate because of the absence


of hypochlbrite in the solution.


3. 	 FOSTER and VARDHEIM (32) describes an observation


whereby Bromine saturated 27 N H2SO 4 can perform


an oxidative hydrolysis of methyl a-D-glucopyranose


into various acidic compounds, among other, traces


of D-gluconic acid. In fact,the total amount of


D-gluconic acid formed either from methyl C-D­

glucopyranose or its decomposition intermedier,


D-glucose is about-2-5 per cent of the starting


-material used.


4. 	 Finally, D-gluconic acid b-lactone can be spon­

taneously hydrolysed into D-gluconic acid according


-to the following reaction scheme:


CH2 0H CH2OH 
H OH 
H 0 
=0 + H2 0 C -
HOH H -
HOO
H OH HOH OH 
GLUCONO-LACTONE 	 GLUCONIC ACID
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D-gluconic acid b-lactone (C6HI00 6) has the following


characteristics:


MW = 178.14,


FORM = CRYSTALS, 
MP = 1530 C (dec.),


COMPOSITION - C 40.45%, H 5.66%, 0 53.89%,


OPTICAL CHARACTERISTICS = Ca 20 + 61.70 C (C=1), 
SOLUBILITY: 59 G/100 ml dH20


1 G/100 G ETOH


Insoluble in ether.


Drop in pH during the hydrolysis: pH 3.6 -- 2.5


within 2 hours (27).


Structure in aqueous solution before the hydrolysis:


D-GA--lactone inw- D-GA-Y-lactone /2/ 
D-gluconic acid - Y-lactone can be produced from D­

glucose using bromine water (33) (marked 5 on Figure


2), in presence of barium carbonate.


Evaluating the available possibilities to experimentally


try the kinetics of chemical formation of D-gluconic


acid under 1-G and O-G conditions, routes 1, 2 and 3


are excluded because of complexity (cooling, electrolysis)
 

and the application corrosive materials (HClO4 , H2SO4).


The most promising technique is route 4 which 1) uses


chemically well defined starting material, 2) hydrol­

ysis may be followed by the decrease in pH (27), 3) the


slope of the change in pH gives indication on the


kinetics and 4) the technique can be expanded to start


from D-glucose and observe the formation of the inter­

medier glucono-D-lactone as well as the formation of
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D-gluconic acid by means of a DO probe (oxidation step)


probably ORP probe (change in eH of the liquid) and


pH probe, ion probe (intermedier - gluconic acid


step). Interference of the probes' signal output


by the presence of Br+-must be checked in ground


based experiments, however.­

5.2.3, ENZYMATIC CONVERSION OF D-GLUCOSE INTO GLUCONIC ACID


1. GENERAL DESCRIPTION OF THE REACTION MECHANISM


Certain.fungi and bacteria (Table IV) produce an


enzyme which is capable of oxidizing D glucose


without the formation of phosphorylated inter­

mediate (-as is the case.of hexokinase catalyzed


conversion of glucose into glucose - 6 - phosphate


(G-6-P)). The enzyme is glucose oxidase


(EC.I.I.3.4.) which belongs to the group of flavo­

protein oxidases.


This enzyme carries out a reaction of general nature


(34):


2 2 HO' 
-- o 2 
b P /3/(E1 ) (E 2 
Accordingly, the flavoprotein oxidase (El) catalyzes


a two-electron removal from the substrate (S).


This is linked to a two-electron reduction of


molecular oxygen. The.initial product (Pl) may


.undergo a nonenzymatic hydrolysis or an enzymatic


catalysis by E2 -to form P2 ­
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Stoichiometry of the E1 catalyzed reaction leading


to Pi can be depicted as:


I 
 El


H-C-XH + O --- C=X + H202 /4/ 
where (in the case of glucose oxidase) -XH = -OH,


E1 is the glucose oxidase and =C=X is PI, i.e.


D-glucono-b-lactone (L).


The 	 other part of the reaction is the conversion


of D-glucono-b-lactone (Pl) into D-gluconic acid


(P2)- This can be accomplished by spontaneous


hydrolysis of P1 into P2 (35) or an enzyme,


lactonase performsthe reaction (06).


Hydrogen peroxide formed during the process can


undergo spontaneous decomposition or catalase


(EC.l.ll.l.6) splits it into 1/2 02 + H2.


Because of the enzymatically facilitated electron


transfer from the substrate to molecular oxygen


(to 	form H202 ) the S --. PI step is composed of


two 	 half reactions, namely:


a. 	 Reductive Half-Reaction (RHR) where the fully
 

oxidized enzyme (Eo) reacts with its substrate


resulting in a sequence of steps:


k, 
 k


Eo+ S I-[Eo.. SIL-.'" [Er.. P1 Er + P1 /5/k- ,­
where Eo is the fully oxidized and Er is


the 	 fully reduced state of glucose oxidase.
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b. Oxidative Half-Reaction (OHR), where the


reduced enzyme transfers the electrons to


the molecular oxygen:


Er + 0 2 KE(H20) /6/ 
The P.-P2 (L--GA) step either catalyzed by


.enzyme or performed by spontaneous hydrolysis is


less complex from kinetics point of view, however,


it yields the final product of interest: D­

gluconic acid.


In accordance to this general scheme, the integrated


stoichiometry of the enzymatically catalyzed decom­

position of D-glucose into D-gluconic acid (with its


side-reactions) is depicted in Figure 3. Because of


this complex nature the two separate reactions leading


to P1 and P2 , respectively, will be treated separately.


2.- GLUCOSE OXIDASE CATALYZED REACTION


2.1. PROPERTIES OF THE ENZYME


Historically speaking, this enzyme was described-as


an antibiotic (notatin) originating from Penicillium


notatum and Penicillium resticulosum sp. nov.,


however, later it was discovered that the H202


produced during the process had bactericidal effect.


Although 'several species of fungi and bacteria


produce the enzyme, currently the best source is


a fungus Aspergillus niger. Since most kinetic


studies were performed with enzyme originating


from A. niger, properties of this glucose oxid4se will


be given in the subsequent chapters.
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CH 2 OH 
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Chemical Composition - The enzyme is identified by 
various authors (38) as a glycoprotein containing 
two molecules of flavine adenine dinucleotide (FAD) 
as prostetic group. Chemical structure of FAD 
(established by CHRISTIE and his coworkers (39) is


given in Figure-4A with an indication of the
 

possible chemical binding points with the enzyme


(marked with arrows on the figure). Accordingly,


the A. niger glucose oxidase is composed of a


dimer having two tightly bound FAD molecules per


dimer (40). YOSHIMURA and ISEMURA studied the


chemical composition of glucose oxidase obtained


from Penicillium amagasakiense (41) finding its


molecular weight of.160,000 and each unit in the
 

dimer composed of two polypeptide chains connected


by a disulfide bond (Figure 4B). According to
 

SWOBODA (42) binding of FAD was shown to be


followed by at least one, and probably two, uni­

molecular steps associated with protein conforma­

tional changes and it was proposed, on the basis of


hydrodynamic and other measurements, that coenzyme


binding converted the loose flexible coil configur­

ation of the apoenzyme to a compact and almost


spherical holoenzyme. Evidence for the sites of


interaction on the FAD molecule was obtained from


studies of the binding of a series of related


nucleotides. The effectiveness of binding was


such that it was proposed that the adenine and


phosphate moieties of FAD are the first to bind,


followed by the isoalloxazine nucleus. Thts.later


part of the holoenzyme is considered to play a key


role in the reaction mechanism.


Chemical composition'and reaction characteristics


of FAD (38) which carries out the electron transfer


result in absorption maxima in the range of 270-280


nm, 375-2380 nm and450-460 nm ranges (27). This


fact plays an important role in the analysis of'


37


N -CNH 
I I 2 
CH C- N H 
C--N H H H 014 OH H H H 
Co 
NH 
CH 3 /'V\Nt1\CO/ 
FAD FAD -H 0 P- -- S-SC-C-C" 
Z.ngr C--Cc O P.amagasakieas 
FAD> FAD 
FAD FAD Is-s 
At..niger P.amagasakiense


glucose-oxidase glucose-oxidase


(40) (4.1) 
FIGURE 4,


(A)STRUCTURE OF FAD; (B)STRUCTURE OF 

GLUCOSE OXIDASE 

38


the reaction mechanism and kinetic behaviour of the


glucose oxidase catalyzed S--P1 step.


MOLECULAR WEIGHT = 150,000 (43), 153,060 (42), 
SPECIFICITY = 	 Data are given in relative rates (38, 
44): D-glucose, 100; D-mannose, 20; 
2-deoxy-D-glucose, 20; effect negligible 
on other hexoses. 
OPTIMUM ENVIRONMENTAL VARIABLES = Temperature ranges


for reaction: 30-350 C, for stability:


max.- 400 C, pH ranges for .reaction:


pH 4-7 with a maximum at pH 5.5, for


stability = pH 4.5-7.0 (45).


PHYSICAL CHARACTERISTICS = Amorphous powder or crystals. 
Solubility = freely soluble in dH20 
giving a yellowish-green solution. 
Stability in storage and in aqueous solution immo­

bilized enzyme. - WORTHINGTON claims storage without


loss of activity for 6-12 months at +40 C (44). De­

hydrated glucose oxidase was found by us to be stable


at 00 C for 22 months without loss of activity (46).


BENTLEY reported that the 0.1-0.2% aqueous solutions


of the enzyme were stable- fot a week at +50 C (47).'


Enzyme solutions became increasingly unstable beyond


the pH ranges of 3.5 to 8.0. The enzyme also exhibits


resistance to thermal denaturation at temperatures


up to 400 C but becomes unstable at temperatures


higher than +400 C. BROUN et al improved the thermal


stability of glucose oxidase by a procedure of cross­

linking the enzyme with glutaraldehyde after its


absorption into a cellophane membrane (48). This


immobilized enzyme could be stored for up to 1 month
 

at 200 C with no loss in activity. There was some


narrowing of the pH activity curve from that of the


soluble enzyme. WEETALL-and HERSH also improved the
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thermal stability of glucose oxidase by covalently


bonding it to NiO on a nickel screen (49). The


kinetic properties of the bound enzyme were similar


to the soluble one. WEIBEL and BRIGHT reported the


immobilization of glucose oxidase on porous glass


using silanization and azo coupling techniques (50).


Nearly 40 per cent of the enzyme protein absorbed


on the glass surface remained enzymatically active.


The loss of some activity could be attributed to


diffusional resistance of the substrate(s) in the­

porous glass matrix. Applicati6n of immobilized


enzyme system may be considered in spacecraft


application because of its improved stability and


because 	 of fluid-mixing characteristics caused by


0-gravity conditions.


+

, Cu++ 
-INHIBITORS Ag+, Hg+ , P-chloromercuribenzoate


- and phenylmercuric acetate. FAD binding


is inhibited with decreasing effective­

ness by ADP, ADP-ribose, NAD, ATP, AMP,


2'-Deoxy ADP and adenosine (51).


CONTAMINATION = Glucose oxidase.may contain impurities 
consisting of catalase (EC.1.II.l.6), 
proteolytic enzymes (27) and lactonase 
(36). 
2.2. 	 DETERMINATION OF GLUCOSE OXIDASE ACTIVITY, REACTION


MECHANISM AND KINETICS


2.2.1. TECHNIQUES


During the period of investigation of reaction mechanism
 

and kinetics several methods were developed, some of


them were also used to determine the enzyme unit. -
The methods include 1) manometric technique, 2) spec­
trophotometry (fluorometry) 3) dissolved oxygen probe 
based kinetic analysis. Each method is described
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here serving as possible technology for the


enzyme mechanism and kinetic studies.


manometric Technique 
 ­a. 

Buffers used: 0.1 and 0.13 M sodium phosphate


buffer, pH 5.6 (52,53). GIBSON et al also


cites use of 0.1 M sodium acetate buffer (53)


of pH 5.6. No difference in results were


observed as consequence of these two different.


applications. According to GIBSON et al (53)


standard Warburg manometers were used. The


rates of oxygen uptake in the presence of pure


glucose oxidase and catalase (100 pg per


manometer) were studied over a range of sugar


concentrations (0.1 to 0.01 M) at pH 5.6, at


00 and 250, and at different oxygen tensions.


The gas space of the manometer was filled with


either oxygen, air (21% oxygen), or 10.5%


oxygen. In general, the amount of enzyme per


manometer was adjusted so-that oxygen uptake


did not exceed 3 p1 per minute. The manometers


were shaken at a.constant rate of 150 per minute.


The oxygen uptakes over 25 minutes were used in


calculating the rate of oxygen uptake, since the


rates were constant for this time.


Limitation of the technique: It is obvious that


a concentration gradient is required across the


gas-liquid layer to permit the uptake of oxygen


in a Warburg manometer. In many applications of


manometry, this gradient may be disregarded,


but not when the kinetics of an enzyme like


glucose oxidase is under study, since the 02


concentration in the liquid phase is one of the


variables in the experiment. The oxygen con­

centration in the liquid phase is always less


than that calculated from the tension in the gas


and the solubility of oxygen, and may be estimated


as given by ROUGHTON (54). When a constant rate
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of oxygen has been reached, it may be shown that:


[0aJ = pO[V - V]/VM 
where [02L is the concentration of oxygen in


solution, a is solubility coefficient of oxygen,


P02 is the partial pressure oxygen in the gas


phase, V is the rate of the enzyme reaction and


VM is the rate of the enzyme reaction at infinite


enzyme concentration, i.e. when the rate is


limited by diffusion of 02.
 

This equation has been-used to estimate the


.errors inherent to the manometric experiments


by limitation of 02; GIBSON et al indicated


that with particular experimentations, errors


in rate measurements are less than 5% within


up to 5 pi per minute with air in the flasks.


With lower 02 percentages, accurate manometry is


scarcely feasible, however, corrections can be


made. .In no-case did these corrections exceed


5% of the value measured.


Besides the possible inaccuracies, another


limitation in space oriented research is the


size and complexity of a Warburg manometer.


b. Spectrophotometric Analysis


Because of the characteristic absorption maxima


in the visible and UV ranges, spectrophotometric


analysis is possible for following the course of the
 

reaction carried out by the flavin part of the
 

enzyme. Also, H202 formation could be followed


spectrophotometrically through its weak tail


absorption at 235 nm. This technique, however,


needs 0.1 absorbance sensitivity and perfect


resolution from the absorbancy of enzyme-bound
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FAD 	 and FADH2 at this wavelength (38). Generally,


the spectrophotometric analysis is performed at


450 nm with tungsten light source using 0.1-0.13 M


sodium phosphate buffer, pH 5.6 (53). A technique


called stopped-flow spectrophotometry was developed


(55) the essence of which is described as explanation


beneath Figure 5 (after GIBSON et al (53)).


With this technique transient-state kinetics can


be measured with respect of the two half.reactions


(Eqs. /5/ and /6/) in the following way:


1. 	 RHR is carried out anaerobically in the stopped­

flow spectrophotometer by mixing E. with S and


monitoring the change of enzyme state at 450 nm.


Changes at this wavelength are shown in Figure 5.


The total number of times that the enzyme must


turn over to exhaust the added oxygen can be


calculated from the conditions of the experiment


and-this number is correlated with the area


enclosed by the curve in Figure 5.


2. 	 OHR is carried out by-mixing Er (usually


prepared anaerobically by reducing Eo in


presence of low concentration of S) with 02


and monitoring the appearance of oxidized


enzyme at 450 nm. In fact, a curve with a
 

reversed shape shown in Figure 5 ought t6 be


obtained.-

From the method of carrying out the stopped-flow


half-reactions we refer to WEIBEL and BRIGHT's


paper (56) which describes the technique in detail.


The combined spectrophotometric and stopped-flow


techniques were widely'used in the reaction
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mechanism and kinetic studies (38) with satis­

factory results.. In our proposed practice
 

it can be utilized only if the crew of the


Space Shuttle or-Spacelab is skilled in


preparation of the enzyme species and carrying


out the spectrophotometric analysis. The


current sizes of spectrophotometers (e.g. B


& L Minispec 20) do not handicap this possibility.


3. Monitoring Oxygen Concentration - The essence 
of the experiment is the measurement of the time


which is needed to exhaust the dissolved


oxygen in a reaction mixture containing known


amount of substrate and enzyme. By this means


the turnover of the enzyme can be determined.


The technique as described by WEIBEL and BRIGHT


is as follows (5.6):


A Clark electrode, power source, and amplifier


assembly were obtained from Yellow Springs'


Instrument Company, Yellow Springs, Ohio.


The electrode chamber was thermostated at"


250 and a1-inch Beckman recorder was used.
 

A 3-ml aliquot of the appropriate glucose


solution was equilibrated by rapid stirring


for 5 min. with air ,or by bubbling 02 into


-the chamber. The-value used for 02 solu­

bility in pure water at 250 and total pressure


of 760 mm is estimated to be- 1.21 x 10-3M.


02 concentrations in dissolved air were


referenced to this value and appropriate


barometric correction were made when signi­

ficant. Low buffer and glucose concentrations


were used when possible in order that the 02


activities measured by the electrode reflect


actual oxygen concentrations. No corrections


were made for salt effects on the solubility


of 02 in the halide experiments as the maximum


concentration of salt was 0.1 M and would only


amount to a maximum error of 3%.
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Addition of enzyme was made to the system


through a groove in the electrode holder using


Hamilton syringes. Since the data obtained


are integral in nature, integrated rate equa­

tions for turnover were used. It was found that
 

a simple three parameter equation (Equation 8)


was adequate to fit all data at the 1% level for


a given pH. Equation /8/ is the integrated form,


of Equation /9/.


Ert=(l/kred, in ([S]o/( IS] o- ( [0 2 10 - 102 1t))) 
+(i/kox) in (102 0/(02 t)+(i/kcat) ([02)0- (02] t) /8/ 
Er/v=l/(kredIS] )+ i/(kox [021) + l/kcat /9/ 
These equations are based on a minimal mechanism


involving two biomolecular steps and one mono­

molecular step in the turnover sequence.


The integral data from measurements at 10 or


more glucose concentrations, in which 02 had


been 80% depleted, were fitted by Equation /8/


by optimizing the three rate parameters.


With this technique pH dependency as well as


effect of halides on the reaction rate were


investigated. Correlation between the stopped


flow half-reaction experiments and the oxygen


probe monitored turnover rate were found to be


excellent (Figure 6) and indicated that the


turnover reaction is zero-order, hence Eq. /9/


can be reduced to Eq. -/10/:


1 
ET/V 
(Ered Is]+ 1/kcat) /10/ 
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Technique using on-line direct measuring DO


probes seems to be an acceptable means to


follow reaction kinetics in Earth-bound


and Space experiments. In addition, changes


in oxidation-reduction potential (ORP) are


also considered as excellent means to define


the half-reaction kinetics. ORP sensors


talike to DO sensors) are available and are


extensively used to monitor biochemical redox


reactions related to both microbiological bio-'


chemistry and animal cell culture physiology


(57). ORP measurement, however, was not tried


so far in connection with glucose oxidase kinetics


measurement.


2.2.2. DEFINITION OF ENZYME UNIT


a. SCOTT defined the unit as follows (27):


"A glucose oxidase unit is defined as that


quantity of enzye which will cause the


uptake of 10 mm 'oxygen per minute in a


Warburg monometer at 30 C in the presence


of excess air and excess catalase with a


substrate containing 3.3% glucose monohydrate.


(33 G/L) and 0.1 M phosphate buffer at pH


5.9 with 0.4% (4 G/L) sodium dehydroacetate".,


b. An other definition-of unit is given by


WORTHINGTON (44). This is based on a spectr­

ophotometric assay. Accordingly "one unit


glucose oxidase is that amount of enzyme


liberating one micromole of H202 per minute


at -250 C." Because of its convenience


(application of spectrophotometer) this assay


is widely used and is described lege artis


from the WORTHINGTON Manual (44).


REAGENTS


Enzyme: Aqueous solution containing 1-4 micro­

grams per ml.
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Buffer: 0.1 M phosphate, pH 6.0.


Coupling enzyme: Aqueous solution of purified


horseradish peroxidase containing 60 units/ml.


Dye: 1% aqueous solution of o-dianisidine.


Substrate: 18% solution of glucose allowed to


come to equilibrium of mutarotation.


PROCEDURE


Add 0.1 ml of o-dianisidine solution to 12 ml


of buffer and place the following into cuvettes


at 250 C. Zero instrument at 460 nm vs


control cuvette.


Test Control


Dye-buffer 2.5 ml 2.6 ml


Glucose 0.3 ml 0.3 ml


Peroxidase 0.1 ml 0.1 ml


-
Enzyme 0.1 ml 
 
Record increase at 460 nm for 2-4 minutes. 
CALCULATION 
D 460/min 
units/mg ­
11.3 X mg enzyme/ml reaction mixture


It is noted that because of the hardware require­

ment (case #(l)) and the necessity to prepare
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samples (case # (2)) these assays canbe


used only for determination of purity of


enzyme preparations and are considered to


be inadequate for kinetic analysis.


2.2.3. KINETICS OF D-GLUCOSE-D-GLUCONO-b-LACTONE STEP


Kinetic strategy includes two classes of operations,


namely: 1) Steady-State Kinetics Study and 2)


Transient-State Kinetics Study. For the first opera­

tion the 02 electrode based technique can rapidly


generate data with relatively high precision. For


the second operation the spectrophotometric (stop­

flow) technique was found to be excellent since the


flavin chromophore is an intrinsic spectrophotometric


probe itself (58). In this second'case the reaction


is broken into two-half .reactions (c.f. p. 51) which


are 	 studied separately.


1. 	 Steady-State Velocity Measurements - According 
to Eq. /11/ the reaction takes place as follows: 
S + Eo Pl + Er. 	 /i/0 
 
Therefore, the steady-state initial activity can be


monitored through the changes in S, 02, H202 P1


concentrations (c.f. analytical methods cited above).


A major source bf error can come from contamination


with catalase where Eq. /11/ is modified to:


20 
r


2S + E. --"-2P + Er /2 
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Consequently, Eq. /11/ can be achieved in presence


of an effective catalase inhibitor (e.g. - CN)


which is inconvenient and halves the-sensitivity


of 02 probe based measurements. Our particular


application, therefore, calls for a quality control


check for catalase-free glucose oxidase to assure


the implementation of kinetics described in Eq. /9/.


According to BRIGHT and PORTER (34) the 02 electrode


trace, at a given concentration of S (which remains


effectively constant during the kinetic experiment)


provides an infinite set of steady-state velocities


as a function of 02 concentration. Such data may


be evaluated by the method of tangents or they may


be analyzed-through the integrated rate equation


by computer or by manual methods. When these methods


are valid, two complete sets of steady-state graphs­

of high quality can be obtained from as few as four


or five kinetic experiments. In addition to rapid


evaluation of the steady-state coefficients such


experiments have the advantage of providing, through


rapid inspection of the 02 trace, useful qualitative

information concerning the relative magnitudes of

crI / [S] and (P, / [02j in the steady-state'-equation.

If (P / [S] <<(P/ [021 (and if both are larger than


cp ,) the 02 electrode trace is highly curved.


This shows immediately that the interaction of 02


with a reduced species of enzyme is a principal

,rate-determining process in turnover. 
 If the opposite


is true, the steady-state velocity remains indepen­

dent of 02 and the 02 electrode trace has constant


slope.


Due to this technical condition the steady-state


turnover data can be obtained as tangents to the


entire 02 electrode trace, usually plotted in


double reciprocal fashion as (Er)/v versus the


reciprocal of the variable substrate (02 or S) at


different levels of the fixed substrate (S or 02)


(see Figure 6). The pair of primary plots usually


consists of sets of parallel lines and the lines


are commonly straight (see Figure 6).
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If these parallel (straight) line patterns are


obtained the steady-state rate equation corres­

ponding to Eq. /11/ can be expressed as:


Er /13/


v Is] 021


where P -1 is the maximum turnover number (in sec-)


-
and I-) and 1p2 2 are apparent bimolecular constants


i -1
 
with units of M- sec .


Notation (P for expression of steady-state rate


equations is recommended by BRIGHT and PORTER (34)


because of the close correspondence of the co­

efficient to rate constants obtained from stopped­

flow experiments (c.f., again Figure 6). It is noted,


however, that: any substrate scheme will give Eq..


/13/ if it contains, minimally, one first-order


(corresponding to cPj 1 ) and two.second-order (corres­
ponding to cpg' and q,- 1 )- kinetic processes and if, 
in addition, along the pathway linking the two enzyme


species-which bind S and 02, there is at least one


process which is irreversible (or practically so)


under the conditions of the experiment. The simplest


possible scheme consistent with Eq. /13/ is, therefore,


that of Eq. /14/ where the first-order process may


terminate either of the half-reactions:


Eo + S. 
 P W
 
k3 = 2


9- Y or Eo
W or X + 02 
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1
kc = co ­2 
 
followed by- W k-bX 
ki = o- 1 
or by

/14/
 
y mEo 
If n rate-limiting first-order processes are located


in either or both of the half-reactions, then the


maximum turnover number becomes:


n 1 ­

i=l1 
It is quite evident that no decisions concerning


mechanism, beyond the generalities just stated, can


be made at this point. However, the steady-state


rate equation, together with the evaluated coeffi­

cients, are indispensable for the correct interpre­

tation of the rapid kinetic measurements. This is


because-the kinetics of each transient inthe rapid


kinetic measurement must correspond to one or more


of the steady-state coefficients if the transient


enzyme species is an obligatory intermediate in


turnover.


According to experimental results obtained from


various sources (34) glucose-oxidase turnover


always conforms to Eq. /13/.


Using 02 sensors integrated steady-state rate


equation can be obtained. The conditions of the


experiments (S >02) force each trace to obey Eq.


*/16/:


[FT] B 

A + /16/


v 02 
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Integration of this equation yields Eq. /17/:


0 2 11 020 A 02o - [Er]


- In - = - +


B /17/

t 02 B 	 t 
 
Comparison with Eq. /12/ shows that B =cP 2 and


A = (Po + qI / [S] . Plots of A vs. 1/S will


therefore yield (Po and . - Although the conditions


for the valid use of Eq. /17/ are strict (no product­

of any kind must interact reversibly with any enzyme


-species), the greater precision of integral, as


opposed to differential, data allows for very


accurate evaluation of the steady-state parameters.


2. 	 Transient-State Kinetics: The Half-Reactions -

Reductive Half Reaction (RHR) takes place according


to Eq. /5/. In case of glucose-oxidase RHR


only the fully oxidized and the fully reduced


species of enzyme can be observed spectrophoto­

metrically. RHR is therefore monitored at 450


nm where E0 and EEO ....S]. absorb maximally


relative to Er. [Er ....PI if it has signifi­

cant lifetime, must have the same spectrum as


Er. If the system is saturated with S, then:


kI 	 kr


S + E 
 0- [E0 • - Er + 	 /18/....S 	 P1 

k-l


and 	 the kinetic equation is expressed as:


1 	 1 k_1 + k2


+ /19/ 
k(obs) k2 klk 2 [S] 
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According to this, it is anticipated that-the plot


of 1/k (observed) versus 1/S is linear indicating


that k-1 is zero. Whether the rate of dissociation


of Pl from [Er ....P2 is actually very rapid as


implied by Eq. /18/ is not known so far (34).


Oxidative Half Reaction (OHR) takes place according


to Eq. /6/. As is the case with [Er ....Pf in the
 

glucose oxidase RHR the presence and lifetime of


[EO ... H2021 is not detected in the OHR experiment


because there is no spectrophotometric change follow­

ing the oxidation of the flavin.


3. Integrated Kinetic Mechanism


On-the basis-of experimental results accumulated so
 

far for flavoprotein oxidase reactions (34),


.Figure 7 presents an integrated kinetic mechanism 

which may be operative in the case of these enzymes. 

Accordingly, two major pathways exist in.regeneration 

of the reduced flavoprotein in one turnover cycle. 

In cycle (A) enzymecomplex [Er ... P11 releases 

the product (PI) and then the still reduced enzyme 

is oxidized forming a--j ... H20 intermediate 

which is decomposed into Eo and H202. In cycle (B) 

-the LEr ... P1 *complex undergoes oxidation re­
sulting in H202 , then the oxidized enzyme parts with 
P1 to yield the -reactive E0 again. 
Identical results between the transient and steady­

state kinetic parameters (34) definitely establish


-Eq. /18/ as an obligatory reaction sequence in turn­

over. They also establish that (P1 is independent


of enzyme concentration (at least in the range of


10- 8 to 10- 5 M where the experiments were performed)


and if there is one FAD per active side. GIBSON et


al (53) found 'P2-1 = k4.for glucose as [S]. This


identity establishes Er -- Eo (H202) as an obligatory


pathway in the turnover. Also, enzyme monitored


turnover experiments (SSK(E)) made it possible to


determine o (53), however, we feel it is not necessary
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[E ........ P] 
 H202 
kr Is] 
k I CS k 2 r 
Eo. o ............. S3- 9 L[Er...Pj
k 1 k-2 
H2 0 2 k9 k3p


[EI3...H202]


Er


k 1 k 2 
k r k 1 + k 2 
FIGURE 7


ASSUMED KINETIC MECHANISMS FOR FLAVOPROTEIN OXIDASES
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to use spectrophotometry based stopped-flow


technique because the turnover number v/ ET


can be computed at any concentration of 02 by


the method of tangents if [s] > [02]


'Accordingly, the overall kinetic equation for


glucose oxidase, if catalytic cycle (A) is
 

operative, is summarized as:


[ET] k 5 (kl+k2 )+k 2 k3 +k 3 k5 k 3 (k_l+k2 ) +kik_ 2 1 
+ + /20 
k2k3k5 k1 k2k3 Is] k4 [j


which equation conforms to the experimental re­

sults obtained with glucose and expressed in.


Eq. /13/.


Considering all of the experimental results com­

piled so far with respect to glucose + glucose


oxidase interaction catalytic cycle (A) is the


most probable hypothesis (34).


3. GLUCONOLACTONE-GLUCONIC ACID.CONVERSION


Completion of D-glucose D-gluconic acid conversion


requires the hydrolysis of D-glucono-b-lactone


(PI) produced by glucose oxidase; According to


Eq. /3/ this step is performed by spontaneous


hydrolysis or the process can be catalyzed by an


enzyme, lactonase. This step was not studied in


detail from reaction mechanism and kinetics point


of view.


Reaction mechanism. Chemical hydrolysis.


Formation of gluconic acid from D-glucono-b­

lactone requires a cleavage on the C-O bond


with an uptake of H+ and OH- ions. The mechanism


Eq. /11/ assumedly follows the classical path of


hydrolysis processes (59).
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Reaction Mechanism. Enzyme Catalyzed Process'


Enzyme, gluconolactonase was described by BRODIE


and LIPMAN (.36) from S. cerevisiae (yeast),


bacteria (not specified), rat liver. The enzyme


protein was purified. 36-fold from yeast cells


and catalyzed the following reaction:


k1


H20 	 + D-glucono-b-lactone 	 -D-gluconic acid /21/


Mg++(Mn{+ C0 ++)


Dependency on bivalent cations was proven. Com­

pared to the non-enzymatic hydrolysis (which was


found to be 0-order) the enzymatic reaction was


of 1st-order nature. Reaction-rate constants


for 	 D-glucono-b-lactone were found (pH = 7.0;


T_= 	 300 C): Ks = 8.5 x 10- 3 moles/ml; km =


5 x 10 3 moles/ml. 6-phospho-glucono-b-lactone


is also described as substrate for eniymatic


reaction. The enzyme's activity was inhibited
 

by NaF, sodium benzoate, hexylresorcinol (in 4


x 10- 3 M concentration).


Out of this relatively small information the


following conclusions can be drawn:


1. 	 The order of the enzymatic reaction indicates


a monomolecular catalytic scheme. It seems


possible that (depending on the enzyme con­

centration) both the nonenzymatic and the


enzymatic pathways exist simultaneously.


2. 	 The initial steps of the pentose-shunt contain


enzyme capable to convert glucose-6-phosphate


(DGL6P). This compound is then converted into


D-gluconate-6-phosphate by an enzyme called


phosphogluconolactonase.. Yeast and bacterial


lactonase had the capability to perform this


latter step, acting upon DGL6P. It is con­

ceivable therefore that phosphogluconolactonase
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also has the capability to use nonphos­

phorilated D-gluconolactone as substrate.


A pentose shunt operates in A. niger (60).


Consequently, phosphogluconolactonase may


be present as a contaminant in glucose oxidase


preparations obtained from A. niger.


5.2.4, MICROBIAL SYNTHESIS OF GLUCONIC ACID


1. GENERAL DESCRIPTION


First reported information on the microbial forma­

tion of gluconic acid from glucose comes from


BOUTROUX (61). Since this time species of several


genera were found to possess the capability to


oxidize the aldehyde group of D-glucose to yield


finally gluconic acid. A list of the species


reportedly having this capability is given in


Table IV. In the case of molds, certain filamentous


fungi have the enzyme structure to convert D­

glucose to D-gluconic acid, whereas bacteria


belonging to the family Pseudomonadaceae particu­

larly Acetobacter (to a lesser extent) and


Pseudomonas genera (to a larger extent) show cap­

ability of bioconversion of D-glucose into


gluconic acid. Most of the species have the


capability to further oxidize gluconic acid into


2-ketogluconic acid which fact, in our case, may


serve as a disadvantage for proper kinetic studies.


However, LOCKWOOD et al reported that P. ovalis


lacks the enzyme system responsible for D-gluconic


acid 2-ketogluconic acid conversion (68). Because


of this property P. ovalis was used in most of


the kinetic studies (72-75) conducted so far with


respect to D-glucose-gluconic acid conversions.


On the other hand Aspergillus niger and Penicillium


chrysogenum species were generally applied to
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TABLE IV 
LIST OF MICROORGANISMS WITH CAPABILITY TO PRODUCE


D-GLUCONIC ACID FROM D-GLUCOSE


MOLDS


Aspergillus fumaricus (64, 65)
 

Aspergillus niger (40, 62, 63)


Penicillium amagasakiense (41)


Penicillium chrysogenum (65, 66)
 

Penicillium luteum purpurogenum (67)


Penicillium notatum (37)


Penicillium resticulosumn sp. nov. (37)


BACTERIA


Acetobacter aceti (Mycoderma acti) (61)


Agrobacter tumefaciens (68)


Corynebacterium michiganese (68)


Bacterium gluconicum '(63)


Bacterium hoshigaki var. rosea (69)


Bacterium hoshigaki var. glucuronicum (69)


Bacterium (Pseudomonas) sovastoni (70)
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TABLE IV


(CONTINUED)


Bacterium xylinoides (69)


Bacterium xylinum (69)


Pseudonomas coronafaciens (68)


Pseudomonas mucidolens (68)


Pseudononas myxogenes (68)


Pseudomonas ovalis (68)


Pseudomonas putidum (71)


Pseudomonasstriafaciens (68Y


Pseudomonas syringae (68)


Xanthomonas begoniae (68)


Xanthomonas campestris


Xanthomonas stewarti. (68)


60


industrial scale production of gluconic acid


(Table V) (63,65), with yield factors of 0.55­

0.971 (Y = gm product produced/gm substrate consumed).


The long fermentation time, however, may exclude


the use of filamentous fungi for Space Shuttle


and Spacelab experiments.


Assumed metabolic pathway in microbial D-glucose­

D-gluconic acid conversion


Figure 8 describes the overall scheme of gluconic


acid formation in presence of microbial cells (X).


Accordingly, the substrate(s) a-D-glucopyranose


is oxidixed by glucose oxidase (E. C. 1.1.3.4.)


into D-glucono--lactone intermedier (L) which
 

is further hydrolysed into the product (P)


gluconic acid. The glucose oxidase activity is


FAD dependent (c.f. 5.2.3.) where the coenzyme


acts as the first electron acceptor in the terminal


oxidation chain. The enzymatic system in P.


ovalis is intracellular which assumes the trans­

portation of substrate through the cell wall.


Since the product is extracellulat there are two


possibilities for the cell wall transport: 1)


the intermedier leaves the cell and then its


hydrolysis takes place extracellularly or 2)


spontaneous hydrolysis takes place intracellularly


and the D-gluconic acid (R-COO-) leaves the cell.
 

In this latter case the release of a compound


with carboxyl ion may need the uptake of an


anion in order to insure the ionbalance across


the cell wall. Hydrogen peroxide as the by­

product of the D-glucose D-glucono-b-lactone


reaction is cleaved into H20 + 1/2 02 by catalase


enzyme. For the sake of the mechanism completion


the gluconic acid-2-ketogluconate step is also


illustrated, however, this NADP dependent enzyme


formation is strongly repressed by glucose (69,


76). This pathway was essentially assumed by the


authors who conducted kinetic studies on gluconic


acid formation (72-75).


TABLE-V


CHARACTERISTICS OE fICROBIOLOGICAL PRODUCTION OF D-GLUCONIC AClID


(AFTER PRESCOTT AND DUNN (69))
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2. COMPOSITION OF MEDIUM FOR P. OVALIS CULTURE


P. ovalis NRRL B-1486 strain can be cultured in


aerated submerged culture having the medium


composition (72,73)shown in Table VI. For


comparison the table also contains the ingre­

dients. used for submerged, aerated culture of


A. niger on industrial scale operations (63).


Characteristics of.gluconic acid fermentation­

.process - Figure 9 illustrates the changes in


glucose, lactone intermedier and gluconic acid


concentrations during the course of a P. ovalis


batch culture (72). Data clearly indicate 1)


accumulation of gluconolactone intermediate (L)


and 2) appearance of unaccountable reducing sugar


at the end of fermentation. HUMPHREY and REILLY


(72) attributed these phenomena to 1) differences


between the kinetic constants of the glucose­

glucono-lactone (kl) and the gluconolactone­

gluconic acid steps (k2), as well as to 2)


appearance of enzyme activity resulting in kinetic


conversion of the gluccnic acid into 2-ketoglucontic


acid when the glucose concentration was lower than


10 G/L. The experiment was conducted at 300 C


and at pH 5.8. At higher pH (pH - 6.0-7.0) value


of k2 increased, therefore no significant inter­

mediate accumulation took place. On the other hand,


the rate of gluconic acid formation was dependent


on the intermediate concentration (Figure 10) (72).


Although the authors defined the correlation with


a straight line a detailed kinetic analysis of


that data indicated that at higher intermediate


concentrations the L-dP/dt correlation is more


sensitive to environmental factors (pH, T, etc.)


as can be demonstrated by a hysteresis curve


drawn by us. Such intermediate-product formation


rate correlations are common in enzyme systems


symbolized as:
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TABLE.VI


COMPOSITION OF MEDIUM USED FOR GLUCONIC ACID


PRODUCER MICROBIAL CELL CULTIVATION


P. OVALIS (72, 73) A. NIGER (63)


(G/L)


GLUCOSE 50.00 240.00


(NH4 ),2HPO 4 0.00 0.42


KH 2PO 4 1.00 0.19


MgS0 4 .7'20 1.00 0.16


AMMONIUM ACETATE 1.00 0.00


YEAST-EXTRACT 2.00


CORN-STEEP LIQUEUR 0.00 3.69


UREA 0.00 0.10


H2SO4 (pH adj.) 0.00 
 0.17


STERILIZATION 121°C, 30' 1210C, 30'


pH (Starting) 5.8 4.5
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kl 
 k 2 
E+S ES -O E + P /22/ 
k- 1 k 2 ' 
where an intermediate(ES) is formed and environ­

mental conditions (e.g. T, pH, etc.) offset the


proportion between k-I/k1 = k-2/k2 (76). In


other words, there is a significant difference


between the P formation rates depending both on


the absolute concentration and the formation


rate of the intermediate. The hysteresis curve


drawn in Figure 10 may also indicate other rate


limiting steps in gluconic acid formation due to


the transport of S, L and P through the cell-wall.


Although the gluconic acid fermentation is one


of the best understood processes, further 1-G


based study is needed to design an adequate set


of experiments which will be used for kinetic


analysis of the biological process intended to


prove or-disprove the advantage of a microgravity


environment on cellular activities.


HUMPHREY and REILLY were successful-in following


-the formation rate of gluconic acid by pH measure­

ment and control (72). In an other experiment


TSAO and KEMPE successfully employed the reaction


kinetics to determine oxygen transfer rate con­

ditions in fermentors (77). This means that at


least two sensors (pH and DO electrodes) directly


inserted into the reaction chamber can provide


signals which have correlation with the process

kinetics. In addition, because of the-presence


of FAD (and possibly NADP+ --bNADPH system)


changes in ORP may be used to follow-the process


kinetics.


Optimum environmental conditions for the P. ovalis


gluconic acid fermentation were searched out in


an off-line, computer based optimization (75).
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Here a model was developed and the PONTRYAGIN's


continuous maximum principle was applied to the


model to calculate the optimum temperature and


pH profiles. Results indicate that the optimum


temperature and pH for glucose-gluconic acid


conversion are 34.20 C and pH 7.0, respectively.


Data seem to correlate findings with regard to


the increased k2 if the pH is increased above 5.8.


5.3. RECOVERY OF GLUCONIC ACID BY ELECTROPHORESIS 
As a general principle electrophoresis is used to


separate charged organic compounds (particularly


amino acids, peptides and proteins) as well as in­

organic ions.


Gluconic acid is recovered from chemical, biochemical,


or microbiological reaction mixtures with conventional


evaporation, and crystallization techniques (e.g.


78-79). However, the present possibility to couple an


experimental bioreactor - EFO apparatus for Space


bioprocessing purposes makes it necessary to evaluate


the possibilities of electrophoretic recovery of GA


from reaction mixtures. In this case, the coordinated


function of the two systems can be readily tested


during the kinetic experimental phase of the project.


5.3.1. IONOPHORESIS OF GLUCONIC ACID 
During the determination of degradation components


of irradiated D-glucose, ionophoresis was used for


separation of the compounds (29). Also, FOSTER


and VARDHEIM (32) used ionoforetic techniques to


analyze the components in a Br-H2S04 reaction mixture.


The two experimental conditions are compiled in


Table VII. According to the reports, D-gluconic acid


could be isolated and detected among various compounds
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TABLE VII


EXPERIMENTAL CONDITIONS FOR D-GLUCONIC ACID


IONOPHORESIS


CONDITIONS- GRANT/WARD (29) FOSTER/VARDHEIM (32)


TYPE OF OPERATION' PAPER IONOPHORESIS PAPER IONOPHORESIS


(51x13 cm)


MEDIUM USED WHATMAN PAPER WHATMAN No.3


QUANTITY OF GA (or liquid) 2.0 ml


BUFFER 0.2M BORATE (pH 10) GLYCINE (pH 11)


POTENTIAL 1,000 V


TIME LENGTH 1.5 HRS.


REAGENT SILVER NITRATE/NaOH SILVER-NITRATE/NaOH (a


ELUTION WATER WATER (Distilled)


TITRATION PERIODATE (b).


(a) TREVELYAN et al, Nature 166,. 444 (1950)


(b) -JACKSON, Org. Reactions 2, 341 (1944)
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including methyl-D-glucopyranoside, D-glucose, D­

glucuronic acid.


1. 	 It is noted that implementation of both techniques


required neutralization of the reaction mixture
 

before introducing it onto the paper. Reagent


for neutralization is not reported in any case.


2. Inophoretic separation of gluconic acid makes it


possible to test EFO based recovery equipment in


conjunction with the biosynthesis apparatus,


and this procedure will serve the purpose of


"tuning" the function of biosynthesis-recovery


subsystems as well as experimentally testing


ordinated function of the bioprocessing apparatus


with its auxiliary equipment.


6, BIOPROCESSING OF HORMONES


6.l," GENERAL COMMENTS


According to WHITE et al (80) hormones are regu­

lators that influence the velocity of cellular trans­

formations. Among their main characteristics the


following are worthwhile noting:


1. 	 Many hormones are essential for basic life functions.


Their absence or excess presence may cause serious


diseases (81). In addition, most current investi­

gations reveal that certain hormones can perform


extrahormonal functions altering mental states and


behaviour. E.g. MSH and ACTH were experimentally


found to improve memory, reduce anxiety (82).


2. 	 Unlike enzymes, hormones do not perform biochemical


reactions, just regulate them. For instance,


insulin regulates the glucose level in bloodplasma,


via facilitating glucose transport through the


cell wall, but does not break down or biosynthetize


glucose (73).
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3. 	 The amount of a hormone necessary to implement


its action is relatively low. For example, the


adrenaline content in normal human blood-is 0.1


pg/ml plasma (83), the growth hormone (GH) is in


-	 a 1-53 pg concentration per one ml plasma to 
exercise its normal regulatory activity (83,128). 
4. 	 Hormonal function is implemented via active inter­

mediates ("metabolic amplifiers').. For instance,


ACTH which regulates the activity of adrenal


cortex, forms a reactive intermediate with cAMP


and thus activates (among others) adenyl


cyclase, phosphorylaseb and cholesterol 20­

hydroxylase enzymes in the adrenal cortex cells.


5. 	 Hormones are biosynthetised by specific endocrine


organs. For instance, insulin is biosynthetized


by the a-cells of the islets of the pancreas. One


of insulin's antagonists, the glucagon is


biosynthetized by the O-cells located in the


same tissue of the pancreas. In some cases the hor­

mone is- biosynthetized in an organ, transferred


fdr 	 storage into an other organ which - upon


regulatory command - releases the hormone. For


exa ple, vasopressin (a hormone influencing


bl od pressure) is made in the hypothalamus but


Itored in the posterior lobe of the pituitary gland.


(83).


6. 	 Depending on their chemical composition the hormones


are categorized as:


- steroid hormones,


- amino acid derived hormones, as well as


peptide and protein hormones.


Table VIII presents the most important hormones


produced by the endocrine glands of some verte­

brates (84). The list indicates the release site


of the hormone, its major effect on cellular
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transformation and the generally used abbreviation


of the hormone. It is noted that in many cases


synonyms are used. The reader should consult


KUTSKY (83) to find the synonyms of a particular


hormone.


7. 	 Hormones interact with other compounds of physio­

logical importance which results in a) enhanced


activity (synergism), b) decrease in effect


(antagonism),-.c) new, specific effect which is


different from the hormone's original effect,


d) hormonal change in the production rate of


hormones. The interacting-compounds are pre­

dominantly other hormones or vitamins. Examples


of interactions are depicted in Figures 22, 23,


24.


8. 	 In addition to these direct hormonal effects on


the metabolism, certain hormones stimulate or


restrict the release of other hormones. Some


non-detailed interactive schemes are given in


Figures 22, 23, 24. For more detailed information


on interactions, the reader should consult KUTSKY (83)


It is also noted, that. modern endocrinology


reveals more and more interactions or direct


effects, therefore, this part of the report needs


updating from time to time.


9. 	 Depending on their chemical composition, hormones


can be chemically synthetized (e.g. thyroxine,


ACTH), microbiologically modified (e.g. some


steroid hormones) or extracted from the producer


or storage organs (e.g. LH (gonadotropin II). In


some cases it was possible to maintain animal


cells in vitro which had the capability to produce


hormones for an extended period of time (84).


Peptide and protein hormones can be recovered and


purified by electrophoresis (83).


Assessing the aforementioned features, it is


apparent that:
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1) 	 Hormones are of utmost importance from both scientific


research and therapeutical-points of view.


2) 	 Despite the fact thatsome (mostlysteroid type)


hormones can be mass produced, many hormones can


not be manufactured in quantities sufficient


enough to perform adequate research or use-them


as therapeutic agents.


3) 	 Because hormones act in relatively small quantities


(c.f. points #3 and #4) even a small bioprocessing


system may have the capability to produce certain


selected hormones for medical research and, later,


for pharmaceutical application.
 

4) 	 Some hormones of scientific and medical importance


were successfully biosynthetized in vitro, using


animal tissues or cells. The potentially advanta­

geous effect of the microgravity environment may


be utilized to enhance the growth and metabolic


activity of cell lines and biosynthetize hormones


with a higher rate. In addition, recovery of these
 

compounds in ultrapure form can be accomplished


with the application of EFO also performed in micro­

gravity environment. Because of this assessment,


in the following chapters the possibility of producing


hormones by animal cell cultures will be discussed.


6.2. IN VITRO CULTURING OF ANIMAL CELLS


Dealing with the possibility of using animal cells for


biosynthesis of hormones, it is necessary to give a


brief outline on the state-of-the-art for propagation


of such cells under artificial conditions. The reader


interested in more detail can obtain further information


from KRUSE and PATTERSON's most recent work (87).
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621. GROWTH CHARACTERISTICS OF ANIMAL CELLS


Table IX presents a comparison on the main character­

istics of microbial and animal cells. These features


are important in the design of vessels and control in­

strumentation for animal cell cultures. Although


the table is self-explanatory, attention is drawn


to the fact that 1) the animal cells regulatory


mechanism is less flexible than that of microbial


cells, 2) the animal cells have decreased capability


to adapt to their environment, 3) they are more


sensitive to their predators and 4) changes in their


genetic structure is, at least to this date, irre­

versible;


Figure 11 shows the differences in the main environ­

mental conditions necessary to successfully propagate


microbial and animal cells.


The first important observation is the relatively


narrow operational range of environmental variables.


This is especially valid for the temperature,


the optimum for vertebrate cells is 370 C with a


minimum 310 C and maximum 390 C, and pH range between
 

6.8-7.8 extremities, with a pH 7.0-7.5 optimum


plateau.


The effect of 02 also shows characteristics specific


to eucaryotic.cells. The available data indicate
 

that-i) there is an optimum in the effect of p02


on cell -growth, 2) the optimum P0 2 and its plateau


varies from one cell-type to another, however, the


average optimum p02 is around 100 mm Hg. This


finding confirms the fact that the 02 content in


the human arterial plasma is in equilibrium with


95 mmHg P0 2 (12% 02) (87), and 3).inhibitory P0 2


als6 varies depending on cell-lines, however, there


is reportedly inhibition of growth as low as 250


mmHg p02 (33% 02).


Carbon dioxide was found essential for protein syn­

thesis and growth. Generally a C02-air mixture is
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introduced into the culture (95% air enriched with


5% C02 ). In addition to this, the preferred way


to establish and maintain pH is the application of


bicarbonate buffer and the addition of C02 gas


into the culture liquid. According to the most


recent informationC02 plays an important role


in the cellular metabolism (88)".


In the past few years, there has been considerable


increase in the attention paid to the effect of


oxidation-reduction potential (ORP) on the growth


of eucaryotic cells (57). There were two important


findings, namely, 1) the initial ORP of the culture


medium defines the growth rate (hence the related


enzyme activities) and the peak yield in cell mass,


and 2) there is a defined ORP domain where the


growth rate of the animal cells is at a maximum.


For optimum growth of L-DR, L, and lymphoid cells, 
ORP = +75 - +100 mV range was found necessary. 
ORP can be manipulated in.many ways: by introduction


of H2, expelling 02 by N2,or addition of compounds


with oxidative-reductive capability (e.g. cysteine,


indophenol, ascorbic acid).


Complex physical stresses are reportedly damaging
 

to eucaryotic cells. Two effects were described,


namely the effect of shear stress (HeLa, mouse L-929


cells: 89,, 90, resp.), and the change in surface


activity because of air bubble introduction (91).


A different chapter could be the question of sterility


of the animal cell cultures. Here, the most important


factors are the filtration of heat labile culture


components (e.g. serum) and the filtration of gases


to avoid Mycoplasma-and virus contamination (92).


Presence of contaminant(s) can upset the metabolic


profile of the culture resulting in difficulties


during the recovery and purification.
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Also, an extensive study is required to define the


nutritional effect (culture medium) conditions.


Particularly, the interactive effects of inducers


and activators on the hormone biosynthesis must be


investigated in detail in the future.


6,2,2, EQUIPMENT FOR CULTURING ANIMAL CELLS IN VITRO


.There is a wide variety of culture techniques and


apparatus for culturing animal cells (86) Figure


12). This is explainable by the technical problems


in establishing and maintaining suitable environmental


conditions for cells isolated from different bodies,


organs, and tissues. The main problem in culturing


animal cells is the fact that, in most cases, the


prerequisite of cell proliferation is the attachment


to a surface, (anchorage dependency, STOKER et al (93).


Although several reports indicate (90, 94) the use­

fulness of solid surface based culture of animal


cells, there are two basic problems related to this


methodology, namely, 1) the growth takes place only


in two dimensions (cm2) and 2) the development of


the cells is frequently limited by an unfavorable


pH value with depletion of 02 or nutrient. There


have been attempts to solve these problems (multi­

surface propagators and perfusion cultures (90, 94))


(Figure 13) nevertheless, the dimensional problem


still remained the controlling factor for large-scale


operation.


Another approach to maintain tissue cultures on


solid surface was the utilization of artificial


capillaries to support growth of cells with anchorage


dependency (95). Basic concept of the operation


is shown in Figure 14. The apparatus consists of


ultrafiltration capillaries (marked 1-4 on the
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drawing). Cells are growing on the outer surface


of the capillaries (see 5 on the drawing) while


the nutrient is circulated through the capillaries


by a pump. This nutrient can be enriched with


gases (02) in a gas permeable capillary (marked 1


on the drawing). Nutrients essential for the cell
 

growth as well as metabolic products from the cells


are diffusing through the capillaries. Type and


pore size of the capillary controls the diffusion


of molecules of various molecular weight. In fact,


the function of capillaries is analogous to the


blood vessels in transportation of nutrients to


and metabolic products from the cells. The gas


exchange capillary is analogous to alveoli of the
 

lung. This technique made it possible to grow human


choriocarcinoma (JEG-7) cells which reached 2.17 x


108 cell density in 3 cm3[ These cells produced


human chorionic gonadotropin hormone (HCG) (c.f.


6'.3.2.) for about 28 days. The hormone diffused


through the capillary and could be recovered from


the spent culture medium.


Since there are similarities between the growth of


microbial and animal cells, there is an interest


in growing mammalian cells in suspension culture


using the knowledge accumulated by cultivating


microbes in submerged culture. The major advantage


of this method is the introduction of the third


dimension (cm3) and the relatively easy way to main­

tain environmental control for optimum growth. The


major difficulty, which still exists to a certain


degree, is that not all cell types show an ability


to grow in suspension culture (c.f. anchorage


dependent).


Basic design concepts of mammalian suspension cul­

ture vessels are shown in Figures 15 and 16; Figure


15 presents a spinner culture vessel which serves


.as perfusion apparatus for cell suspension cultures


(96). The cylindrical filter spins at a rate of
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300 r.p.m. and allows culture medium to be aspirated


out of the culture as fresh medium is perfused into


the vessel, without clogging of the filter by the


cells. At perfusion rates of the order of 75-100


ml/hr cell densities approaching 108 cells/ml have


been achieved (26).


An other suspension culture system (97) contains


peripheral 'equipment including medium mixing, steri­

lization subsystem,seed culture vessel and cell


propagator, control elements for maintaining the


optimum environmental conditions during the cell


culture. In both cases the cells are.kept in


suspension by mild agitation of the culture liquid.


Suspension culture systems were found scaleable up


to 3,000 liter liquid volume (90). One system
 

including all of the elements similar to one depicted


in Figure 16 was designed in cooperation with ACTON


and LYNN and is operating in a semi-continuous mode


at University of Alabama at Birmingham, Ala. since


1975- (98), producing about 101 2 lymphoblastoid


cells per week in a 500 liter culture liquid.


As it: was mentioned, not all animal cell lines have


the capability to grow in suspension. A technique


developed by VanWEZEL and his coworkers (99) tried


to overcome this difficulty using SEPHADEX or DEAE


cellulose beads as microcarriers. Cells with anch­

orage dependency are growing on the microcarrier


surface while the microcarrier beads are kept in


suspension by agitating the aerated culture medium.


Based on the experimental data, Table X compiles


the maximum animal cell numbers achieved by various


culture techniques. Here the initial (Cb ) and 
­
final (Ct) numbers are given in a unit volume (ml).


It is noted that 1) the initial cell number to


start an animal cell culture of any form must be
 

between 1 x 105 - 1 x 10 cells/ml and 2) maximum
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TABLE X


COMPARISON OFANIMAL CELL YIELDS OBTAINED


WITH DIFFERENT CELL CULTURE 	 TECHNIQUES


CELL TYPE 	 CULTURE TECHNIQUE 	 CELL CONCENTRATION (1)


PRIMARY MONKEY KIDNEY MONOLAYER 	 CO = 1 X 105


CT = 11,2 x 105


WI-38, VA 13A 	 MULTILAYERJ CO = 2,04 x 105


PERFUSION CT = 1.01 x 107


BIIK-21 	 SUSPENSION 	 C = 0,5 x 106
o 

CT = 7 x 106


BHK-21 	 MICROCARRIER Co = 1 x 105


SUSPENSqON 
_CT = 1.6 A 106


CHORIOCARCINOMA HOLLOW-FIBER CO = I x 10


JEG-:7 CT = 7.23 x 107


L1210 LEUKEMIA SPINNER-CULTURE CO = 8 X 105


7
CT = 9X 10
 
=
(1) Co INITIAL CELL NUMBER AT THE TIME OF SEEDING 	 (CELL/M)


CT=FINAL CELL CONCENTRATION (CELL/ML)
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cell number of 1 - 9 x 107 cells/ml was achievable 
using various culturing techniques-. Microcapillary 
(hollow-fiber) and spin filter suspension culture


techniques were found to yield the maximum cell


number (95, 100).


The possibility to achieve three dimensional cell


growth in microgravity conditions was discussed by


BRADVAROVA et al (101). Apparently, cells with


anchorage dependency can be grown in suspended


form in a soft (0.035%) agar. Gravity adversely


influenced the growth rate as well as the physio­

logical conditions of the cells. These findings


were corroborated exposing Staphylococcus cells to


various gravity conditions (102). On the basis


of these preliminary findings it is expected that


in microgravity conditions cell growth patterns


will be also altered (103). The expected direction
 

of change is toward the accelerated growth rate


and/or the increased cell density (13, 104). This,


in case of a growth related hormone biosynthesis


(95), substantially enhances the hormone production


rate.


6,3. PRODUCTION OF HORMONES BY ANIMAL CELLS


There is increasing evidence to suggest that


many currently known mammalian-hormones could be


produced by in vitro culturing of animal organs


or cells (105). In particular, some hormones have


already been produced using animal cell cultures. These


are listed in Table XI. Reviewing the literature


and comparing this list with the one given in Table


VIII, it appears that 1) so far, it was possible to


produce at least 50 per cent of the essential hor­

mones culturing animal cells in vitro, 2) in many


cases the in vitro biosynthesis of hormones was


accomplished using malignant cells which generally


have the capability to be cultured .in suspension,
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TABLE XI


LIST OF HORMONES PRODUCED BY MAMMALIAN CELL CULTURES


HORMONE 	 CELL TYPE TECHINIQUE REFERENCE

(ORIGIN) (CULTURE)

STEROIDS

4-3-KETOSTEROIDS 	 CLONAL TESTICULAR (106)

LEYDIG CELLS

HYDROEPIANDOSTERONE 	 EMBRIONIC TISSUE (107)

GONADAL (CHICKEN)

TESTOSTERONE 	 EMBRIONIC GONADAL TISSUE (107)

(CHICK, MOUSE)

ANDROSTENEDIONE EMBRIONLC GONADAL TISSUE (108)

ESTRONE EMBRIONIC GONADAL TISSUE (108)

ESTRADIOL EMBRIONIC GONADAL TISSUE (108)

AMINO ACID DERIVED
 
THYROX-INE (TOj 	 NONMALIGNANT TISSUE .(109)

THYROID

EPINEPHRINE 	 ADRENAL CORTEX (111)

TUMOR

NOREPINEPHRINE
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TABLE XI


(CONTINUED)


HORMONE 	 CELL TYPE TECHNIQUE REFERENCE


(ORIGIN) 	 (CULTURE)


PEPTIDES AND PROTEINS


PARATHYROID 	 PARATHROID (85)


ADENOMA


INSULIN 	 NORMAL PANCREATIC SUBMERGED (113)


ISLETS


1-CELL ADENOCARCINOMA


GLUCAGON "NORMAL PANCREATIC SUBMERGED (113)


ISLETS


GH 	 PITUITARY SUBMERGED (109)


ACTH 	 PITUITARY SUBMERGED (106)


HCG 	 TROPHOBLASTIC TISSUE (114, 95)


(BEWO) (PERMANENT) MICROCAPILLARY


HUMAN CHORIOCARCINOMA


JEG-7 (PERMANENT)


CALCITONIN HUMAN MEDULLARY TISSUE (85, 115)


CARCINOMA OF THYROID


PROLACTIN 	 PITUITARY 	 (110)


THYROGLOBULIN 	 NONMALIGNANT TISSUE (109, 112)


(PROHORMONE) 	 THYROIDi MEDULLARY


CARCINOMA OF THYROID
C2
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3) some permanent cell-lines could be established


(85, 121) but even in the case of loss of the cell­

line; primary.cell-cultures could be obtained from


fresh tissues (86, 119, 121).


In the following sections two examples are given


demonstrating the possibility for production of


hormones of medical importance using in vitro mammalian


cell cultures. The hormones are: 1) Growth Hormone


(GH') and 2) Human Chorionic Gonadotropin (HCG).


631. GROWTH HORMONE PRODUCTION IN VITRO 
Extensive studies were conducted since 1965 to produce


GH by various techniques (116). A basic cell line


was successfully developed (GH3 ) originating from a


rat pituitary tumor. Cells could be cloned (at least
 

twelve serial- clones of GH3 were obtained, each clone


.derived from a single cell of.the preceding clone)


and had the capability to grow in monolayer tissue


and in suspension culture.


-Culture requires HAM's F-l10 Medium (available from


Microbiological Associates, 5221 River Road, Bethesda,


Md. 20016, 1976 Catalog No. 12-618) supplemented with


15% horse serum and 25% fetal calf serum. Growth


temperature is 370 C, in a humidified'atmosphere


containing 5% CO 2 + 95% air.


The cells simultaneously produce GH and prolactin.


Based on microcomplement fixation assay (117) both


hormones can be measured. No correlation has so far


been investigated between the production of hormones


and other process variables (e.g. changes in pH,


ORP, oxygen consumption rate) as it was accomplished


in the case of micrbbiological cultures (21). Figure


17 presents the GH production rates expressed as pg


hormone produced per mg cell protein per 24 hours


(118). Three important factors are worth noting:
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1) The hormone production rate changes with elapsed


culture time; whereas the production of GH increases,


the prolactin production decreases, 2) there is a


definite regulating effect of hydrocortisone in the


production of hormones. -This is in accordance with


observations on the interactive effect of hormones


both on production and action levels (c.f. p. 72).


Such regulatory effect is observable using 17 -estradiol


to increase prolactin production at the expense of


GH (Figure 18), 3) regulatory effect of other hormones


8
takes place at low level (e.g. 5 x 10- 7 3 x 10- 6 M


in case of hydrocortisone, i0-9 M in case of 17


P -estradiol). TASHJIAN's group reports a lag period


of 24-36 hours between the addition of the regulator


and its effect.


In another series of experiments, human pituitary


cells from various origins were cultured. The


culture conditions were essentially the same as in


the case of GH3 cells. Hormone production was main­

tained for 60-405 days. In one reported case,


TASHJIAN's group was able to establish clones of


human pituitary adenoma cells which actively secreted


human GH. The hormone produced this way was immuno­

logically authentic with human growth hormone (85).


These data indicate a high probability of cloning


pituitary cells for in vitro production of hormones,


particularly GH which is currently among the rarest


hormones. It was also noted recently that it was


possible to culture calf anterior pituitary cells


in microcarrier suspension culture with a result of


increased number of active cells (5 x 106 cells/ml (120).


6.3.2, -HMAN CHORIONIC GONADOTROPIN HORMONE (HCG) PRODUCTION


IN VITRO


Perhaps the-most successful attempt to produce hormones
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by means of in vitro animal cell cultures is the


biosynthesis of the human chorionic gonadotropin
 

hormone (HCG). This hormone is comparable in bio­

logical action to the pituitary luteinizing hormone­

(LH).


According to PATTILLO (121) it was possible to ex­

plant trophoblastic tissue from a malignant placental­

tumor (choriocarcinoma) (114) and-maintain it by


means.of serial transplantation in animals. Most


recently four additional lines and clones were
 

obtained (121) directly from patient biopsy without


animal transplantation. Hormone production could


be maintained for several weeks.


The best culture medium is composed of WAYMOUTH's


Medium (50%), GEY's BSS (30%) (available from Micro­

biological Associates, Catalog No. (1976) 10-505)


with phenol red, supplemented by 20% human umbilical
 

cord serum. Antibiotics (penicillin: 100 IU% and


streptomycin: 20 mg%) may be used to enhance the


sterility conditions. Phenol red indicated some


metabolic changes. -This indicates that it is possible


to find correlation between the cells metabolic acti­

vity and changes in environmental conditions (e.g.


p11) which is essential to control of bio­

logical processes (21). The cells were cultured in


multilayer form. HCG was produced together with


progesterone and estrogen but the production rates


varied depending on the type of culture medium.


Maximum production rate was 1000 IU per 108 cells


per 24 hours.


KNAZEK et al reported a technique to propagate


choriocarcinoma (JEG-7) cells in a density which


reached the one existing in normal tissues (95).


The basic apparatus KNAZEK and his coworkers used


is described in Section 6.2.2. (p. 80 ). 
Figure 19 presents the apparatus (a); and the results


(b) in terms of HCG production rate. In the experi­

mental case HAM's F-10 Medium was used (83:3%),


with 13.5% horse serum, 3.2% fetal calf serum,
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5,000 IU% penicillin-G, 5 mg% streptomycin, 0.5%


mg% insuline and 0.62 mg% cortisone acetate (pH


7.3 T = 37%). Culture liquid was circulated with


a rate of 42 ml/hr through the capillaries. Con­

tinuous replacement of medium enhanced the transfer


of nutrients to the cells and resulted in the re­

moval of metabolic products.


After a lag period of 5-7 days the production rate


increased with doubling in every 1.1-1.2 days. It


is noted that the maximum production rate (500 IU


HCG/day) was obtained from a culture which was


equivalent to 2.17 x 108 cells in about 3 cm3 space.


HCG production rate increased with the increase of


culture medium circulation rate to 300 ml/min.


Stimulative effect of various hormones on the pro­

duction has not been experimentally tried yet.


6,4, RECOVERY OF HORMONES


Depending on their origin and chemical character­

istics, hormones can be recovered by various techniques


(83). Figure 20 describes four essential ways to


obtain hormones. Sources of hormones are either


1) animal (organs, tissues or excretum), 2) animal


tissue (suspension) cultures, 3) hormone raw materials


(precursors) which can be converted either micro­

biologically or by chemical synthesis. Roman numbers


in the drawing indicate essentially analogous steps


in the processes. Whatever are the raw materials and


the production steps, the hormone in its "crude form"


contains substances (as contamination) which must be
 

removed by means of various recovery-purification


techniques to obtain clinically useable products..


-Table XII gives a list of some selected hormones of


medical importance indicating their status in the


commercial production, purity and the current source


for production. It is noted, that despite the
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TABLE XII


SOURCE AND COMMERCIAL AVAILABILITY OF SOME HORMONES OF MEDICAL IMPORTANCE


HORMONE COMMERCIAL MW CHEMICAL GLAND PLACENTA URINE BLOOD INVITRO UNITS


PROD. SYNTHESIS (TISSUE)


(1) GH 21,500 + + + + + 1 USP M1
iU 1 MG


(2)HCG + 67,000- + + + Iliu, 
68,000 
(3)ACTH + 45,000 + + + 1 usp = 1 iU =1.14 M 
(4)T4 + 776.9 + + + MG
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possibility to chemically synthetise (at least T4


and ACTH) as well as producing them by tissue cul­

tures, T4, ACTH and HCG are still manufactured by


extracting animal organs (glands) or from urine'


(GH, HCG) as well as human blood plasma (GH).


Because of the difficulties in obtaining raw materi


currently G1 is not available commercially, there­

fore, its price could be only estimated. Tables


XIII-XVI present the outlines of current recovery


techniques by which the best purities of some hor­

mones were ever achieved.


From technological point of view, these complex


extraction, recovery-purification operations can


be eliminated if a) the water soluble hormones are


produced by tissue cultures and are secreted by


the cells, b) their molecular weight makes it


possible to pass ultrafiltration or dialysis mem­

branes. These conditions make it possible to


recover the hormones from tissue culture fluids


(see Steps IV-V) and purify them (Step VI) directly


by means of.electrophoresis.'


As.examples show, with the exception of T4 , hormone!


cited in Table XII are water soluble. Also, there


is direct experimental evidence that HCG passes


ultrafiltration capillary (95). In addition, being


all quoted hormones peptides or proteins, they can


be directly recovered and purified using EFO tech-,


nique. .In the case of ACTH, this technique was


already utilized (c.f. Table XV).


Comparing the currently used techniques for hormone


preparation with cell culture based biosynthesis,


dialysis type product extraction, and EFO based


recovery-purification techniques, the following


advantages can be anticipated:


1. 	 Tissues (cell suspensions) are cultured in a


defined environment, therefore, the production.
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TABLE XIII


H EXTIAJIQN - PURLFICATION 
PITUITARY GLAND


ACETONE


DRIED GLAND POWDER


ACETONE,700c


:ACETIC ACID


] GLAND POWDER


" -- CETONE + ETHER


OXYCELLULOSE FRACTIONAL PRECIPITATIO


L" ACTH "i GH + IMPURITIES


ETHANOL


PRECIPITATION


4.4 H PURIFICATION


4,4%__}GEL FILTRATION


GH


0.5 I,U,/MG


(FIVE BANDS)


(1)RABEN, M.S., RECENT PROGR, HORMONE RES, 5, 71 (1959)
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TABLE XIV


HCG EXTRACTION - PURIFICATION
(1)


URINE + HCG


ACIDIFICATION


COLUMN CHROMAT"


HCG ON PERMUTET URINE


.ELUTION


38% ETOk


10% AMM. ACETATE


CRUDE HCG


PRECIPITATION


ETC H


ION EXCH.


(DECALSO)


PURE HCG IMPURITIES


12,0 I.U./MG


(1) MORRIS CJO,R,. ACTA ENDOCRINOL., COPENHAGEN, SUPPL,

90, 16t (1964)


99


TABLE XV


ACM EXTRACTIO - PURIFICATION


OVINE GLANDS


EXTRACTION


CH3COOH + ACETON


S DRY POWDER


ABSORPTION


OXYCELLULOSE


" CRUDE ACTH


FRACTIONAL PRECIPITATION


ACTH [IMPURITIES


PURIFICATION


EFO, PH 11,1


' 
 ACTH _

I AMBERLITE IRC-50


(XE-97)


, ACTH _ 
1500 X PURIFICATION 
S-BUTANOL + 0.2% TRICHLOROACETIC ACID 
ACTH TRIACETATE


150 I.U./MG


(12 MG/KG PITUITARY GLAND)


(1)LI, C,H. E_ AL. NATURE (LONDON) 173, 251 (1954)
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TABLE XVI.


T4 EXTRACTION - PURIFICATION (1)


THYROID TISSUE


TRYPSIN HYDROLYSIS


PH 8.4, 24 HRS., 370C


IODINATED COMPOUNDS


EXTRACTION


S-BUTANOL + HCL


OR


CH3OH + NH4OH


T4 +TRIIODOTHYRONINE 
 [ODINATED COMPOUNDS


PARTITION CHROMATOGR,


KIESELGUHR + 5N NAOH


.20% v/v CHLOROFORM


PURE"T4 TRIIODOTHYRONI'NE


IN MG


(1)TONG, 1.AND CHAIKOFF, I.L., J. BIOL. CHEM, 232, 939 (1958)


rates and yield are more controllable than using


organs or animal-exeretums as source materials.


2. 	 Composition of tissue or cell suspension culture


nutrients is generally known, therefore, the


nature of contaminants from which the hormones


are extracted is defined. This simplifies the


recovery-purification technology.


3. 	 Tissue cultures were successfully utilized to


produce certain hormones including GH, HCG, ACTH,


T4 and many others (see Table XI). In case of


GH production, tissue culture technique seems


to be economically more feasible than any other


formerly used methods.


4. 	 Development of a tissue (cell suspension) culture


based biosynthesis, dialysis based product ex­

traction and EFO based recovery-purification


technique for peptides and proteins opens up a


novel way to produce compounds of ph-armaco­

logical significance. As it was noted formerly


(82), one of the tendencies in the phsycho­

pharmacology is to define the extrahormonal


effects of certain brain peptides and hormones


(e.g. ACTH). Should this research (122) prove


to be successful, the novel technique developed


for hormone production can be adapted to pro­

duce such substances for broader experiiental
 

and therapeutic applications.


5. 	 If (as expected) the microgravity environment
 

enhances the cellular metabolic activities and


(as it was demonstrated) improves the resolution


of EFO based separation of charged particles,


a technique primarily developed for hormone pro­

duction can be utilized in the space to manu­

facture peptide-protein type compounds of medical,


scientific importance on commercial scale.
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6.5. HORMONES AS CANDIDATES FOR SPACE BIOPROCESSING


6.5.1, OVERVIEW OF THE POSSIBILITIES


Some aspects for selection of organic compounds for


space bioprocessing were already discussed in Chapter


4.1 (p. 15). The selection criteria included:


1) Social need for the substance,


2) Efficacy (as a result of mode of action),


3) Cost of operation,


4) Cost/efficacy ratio.


As examples: a) Food (e.g. Single Cell Protein


(SCP)); b) Pharmaceuticals (e.g. antibiotics,


vitamins); and c) Body Metabolism Regulators (e.g.


hormones) were quoted.


There is Social Need for each class of substances


and it is foreseeable that this need will increase


in the future (123, 124).


Efficacy of the substances in the first two classes


is correlated with the absolute quantity administered


into the body. This is particularly valid in the
 

case of SCP, wher:e the daily intake serves the purpose


of maintenance of nitrogen balance of the body (125).


Because of the mode of action and the social need


of the substances belonging to categories a) and b),


mass production was developed in the past 30 years


(c.f. 123, 124 and partially Table XVII). In view


of current state-of-the-art, there is a small likelihood


of constructing and operating a SCP or antibiotic


producing fermentation plant in Space with any chance


being economically viable with existing or future


terrestrial operations. The biggest technical


handicap is the recycling of waste water (c.f. Table


I for product concentration data) after the recovery
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TABLE XVII


COMPARATIVE PRODUCTION DATA ON VARIOUS PHARMACEUTICALS


(U.S, PRODUCTION)

PART I (124) 
COMPOUNDS QUANTITY VALUE$)UNIT VALUE


COMPOUNDS 
 (TONS) (U.S. $) ($)
PER LB.


1971 1974 1971 1974 1971 1974


ANTIBIOTICS (TOTAL) 8,110 9,300 136.7M 254.5M 20.5 30.8


Penicillins 3,400 3,500 27.3M 47.6M 9.98 11.5


VITAMINS (TOTAL) 11,800 18,500 106.6M 158.7M 5.08 5.38


Vitamin B 4,200 - 39.6M - 5.65 -
Vitamin C 6,200 10,000 20.4M - 1.81 
HORMONES (TOTAL)* 62.0 53.0 15.1m 61.2M 98.56 514.49


Unit value of hormones incorporates the price of all US produced


hormones including steroid, peptide-protein type ones. Price of


some specific peptide, protein hormones proposed for space


bioprocessing is estimated in Table I (average), and in the


continuation of Table XVII (specific).
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TABLE XVII


COMPARATIVE PRODUCTION-DATA ON VARIOUS PHARMACEUTICALS


(u.s. 	 PRODUCTION)


(Continued)'


PARTII 
REPRESENTATIVE PRICES QESOME PEPTIDE-PROTEIN HORMONES


HORMONE PURITY UNIT PRICE* ($)


ACTH CHROMATOGRAPHICALLY $11,600/g


PURE


HCG IMPURITIES PRESENT $900-$1,200/g


GH** FROM HOG, $240/g


PARTIALLY PURIFIED


* SIGMA Catalog and Price List (1975)


** SIGMA Catalog and Price List (1972)
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of the main product. The waste water treatment in


the space increases the operational cost, hence,


the efficacy/cost ratio decreases.


On the other hand, hormones act as regulators of


metabolic functions. Their action is amplified


via intermediates (see p. 70); therefore, extremely


small quantities (expressed in pg or qg amounts)


are necessary to perform normal functions. Currently


hormones are still manufactured (with the exception


of some steroids) from animal organs or excretums


(see Tables XII-XVI), the quantity produced is


relatively small as well as the price is high,


compared to other substances of pharmaceutical


importance (Table XVII).- Based on the possibility of


producing some important hormones by means of in


vitro culturing animal cells and simplify the-re­

covery technique, there is a chance to manufacture


some of these substances with a novel technology


which, if developed, would be competitive with the


"classical" processes even under terrestrial con­

ditions.


6,5.2, SELECTION OF HORMONES FOR SPACE BIOPROCESSING


Based on the technical feasibility and the relative


economic value and, in agreement with other evalu­

ations (130), hormone production was proposed as a


primary (experimental) objective for bioprocessing


of substances of importance in Space (23). A


further analysis seemed to be necessary, however,


to define some of the hormones which may be con­

sidered as candidates for experimental trial.


Criteria for the selection were set as follows:


1) Scientific or medical significance,


2) Possibility to develop competitive technique
 

with the currently -existing production


technologies, using animal tissues or cells,
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3) A possibility that the technology developed


for the space bioprocessing can be adapted


to manufacture other peptide-protein type


substances either on Earth or in


Space.


Accordingly, we propose one or more of these hor­

mones for consideration: 1) Human Growth Hormone
 

(HGH), 2) Human Chorionic Gonadotropin Hormone


(HCG), 3). ACTH, 4) Thyroid Hormone (T4).


As it was shown previously, all of these fulfill


requirements in criteria 2) - 3). In particular,


a) there are demonstrated cases to produce the


listed hormones in vitro, by means of culturing


tissues or cells of various animal origin, b) if
 

developed, the technique will offer a simpler and


more controlled method to produce as well as to


recover-purify the substances, c) scale-up can be


assured by the proper design of the biosynthesis­

recovery equipment and d) since these substances


are of'peptide-protein nature, the developed


technique can be adapted to other materials of


similar chemical composition (e.g. vaccines, other


proteins (peptides) of medical significance).
 

In order to analyze criteria 1), -t is necessary


to give a brief assessment on the importance of­

ea6h proposed substance in the scientific and


medical fields. Generally, the following is noted:


1) 	 Because of the interactive nature of


hormone action, every hormone acts directly


or indirectly in various ways. Therefore,


GH is not only a therapeutic agent used
 

to treat dwarfism or obesity, but acts


synergistically or antagonistically in


many other cases.


2) 	 Because of the low level of productivity (or


even the lack.of commercial'production) many
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areas for the applicability of these hormones
 

were scarcely investigated. Therefore,


development of techniques for large scale


production will provide material enough to


expand the scope of experiments.


3) ACTH, 1ICG and T4 are commercially produced


and their efficacy is prescribed in United


States Pharmacopeia (126)-. 'Therefore, studies


can be made to compare the yield, efficacy,
 

and purity obtained using novel techniques


for production.


1. GROWTH HORMONE (GH)


Figure 21 presents the amino acid sequence of


the purified Human Growth Hormone (HGH) as


well as its main chemical characteristics (127).


There are significant differences between the


MW and immunochemical behaviour of growth


hormones obtained from various animals. However,


bovine growth hormone (BGH) having a MW of 45,000


can be digested with trypsine resulting in a


preparation which is metabolically active in


humans and immunochemically reactive with anti­

human growth hormone. MW of a trypsine digested,


purified BGH is 22,000 indicating a subunit'


configuration with a unit molecular weight of 22,000.


GH obtained from rats (RHG) hag MW = 46,000 which


also hints of a polymer formation from 21,500 MW


subunits. Rat GH3 cells were found to be good


producers of (RGH) in vitro (85). No further


experimental evidence was found, however, regarding


treatment of RGH with trypsine and comparison of


the product's chemical and immunochemical


features with those of HGH.
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Figure 22 gives an outline of the interactive


mechanism involved in control of GH secretion


and its mode of action on various metabolic


activities (128). In particular, the inter­

active effect between HGH and insulin, effect


of GH on GRH secretion from hypothalamus,


effect of GRH on GH activity as well as regu­

latory effect of GH on fatty acids are noteworthy.


The initial recognition of the pituitary's


relationship to growth came from the corre­

lation of gigantism, dwarfism, and acromegaly


(due to hyperproduction of GH in adults) with


pathology of that gland. Associated with growth


is a markedly positive nitrogen balance; GH


causes a reduction in plasma amino nitrogen,


increases amino acid transport across cell


membranes, and increases protein synthesis.


Growth hormone- causes mobilization of non­

esterified fatty acids from fat deposits


while it also inhibits glucose utilization


by muscle tissues and decreases the sensi-'


tivity of hypophysectomized animals to insulin.


The first of these actions is the so-called


ketogenic.effect and the latter two are


diabetogenic actions.


Current studies on GH action point to a role


in the transcription or translation steps


leading to protein biosynthesis. Growth hormone


has also been reported to stimulate transfer


RNA (tRNA) and 	 messenger RNA (mRNA) formation


(128).


In accordance with'the findings with respect


to the interactions of GH with other body


mechanisms, its role of medical importance


can be listed as follows:


Treatment in: 	 - pituitary dwarfism,


- obesity,
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Potential use in:


- hyperglycemia treatment,


- T4 related diseases (c.f. p.::


GH's role in scientific research can be identifJ


-in the areas of:


- protein biosynthesis, 
- ribonucleic acid biosynthesis, 
- regulation of metabolic activities related 
to energy producing processes, 
- regulation of the biosynthesis and secretion 
of hormones, ­
- interactive control of hormonal regulation of


organs' metabolic function (e.g. interaction


with cAMP, prostaglandins).


2.- HUMAN CHORIONIC GONADOTROPIN HORMONE (HCG)


Although HCG has not been purified yet, the


compound used for therapeutic purposes contains


peptides and carbohydrates. An approximated


MW was determined to be about 30,000 (128) with


about 30% carbohydrate content (which may be


contamination) composed of glucoseamine,


galactoseamine, mannose, and fucose.- Also,


8% sialic acid was found. The isoelectric


point of HCG is 2.35.


The role of HCG is similar to that of luteinizin


hormone (LH-). Regulation of its secretion as we


as its action is complex and is somewhat diff­

erent in males and females. Figure 23 shows


the interactions relative to LH secretion and


its effect on various organs. Note the strong


interactive function of LH with steroid hormones


controlling sterility-fertility conditions in


females. This generalized version of the mode
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of action (128) also points out the role of


hypothalamus in the secretion and action of LH.


Currently, HCG is used in the therapy in the


following areas (81, 129):


ovarian diseases,


- hypogonadotropic eunuchoidism,


- cryptorchism, 
- -hypogonadism, as well as in 
-. obesity. 
Areas of scientific research may be related to


further explore the applicability of HCG in


conjunction with steroid hormones related to


birth control - family planning;


3. 	 ADRENOCORTICOTROPHIC HORMONE (ACTH)


This hormone is a single chain polypeptide


consisting of 39 amino acid residue and having


a molecular weight of about 4,500 (Figure 24).


It is noted that the amino acid sequences of


ACTH from four animal species (pigs, cattle,


sheep, humans) had been determined. Although


differences can be found (in the amino-acid


sequence from 25 to 33) this does not alter the


hormone's biological activity.


Figure 25 presents the regulation of secretion


and interactive effects of ACTH. Again, a dual


neural control of hypothalamus is observable.


Sites of action of ACTH are:


1. 	 Effects on zona fasciculata and zona


reticularis in the adrenal cortex resulting
 

in the biosynthesis and secretion of gluco­

corticoid substances. This function is


performed by means of reduction of ascorbic


acid content, conversion of cholesterol to


glucocorticoids, increasing the metabolic
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rate of the tissues (enhanced 02 and glucose


uptake), increases the adenylcyclase


activity resulting in cAMP biosynthesis


and enhances the steroidogenesis.


2.-	 Regulating the deposition of fats creating


lipolytic action (similar to the effect of


HGH, TSH and catecholamines),


3. 	 Stimulates melanocyte formation (similar to


melanocyte-hormone (MSE) effect) causing


darkening of skin.


Current therapeutical application of ACTH is


to:


- acromegaly,


- adrogenital syndrome,


- thyroid diseases.


Potential research areas are related to
 

- cAMP related control of cellular activity,


- obesity,


- experiments related to psychopharmacological


substances (improving memory, reducing anxiety,


etc. (82, 122)),


- interactive effects of hormones.


4. 	 THYROID HORMONES


In particular we refer to L-thyroxine (T4)


which is one of the thyroid hormones. Its


chemical structure (and its chemical syn­

thesis) is well defined (although this


compound is still manufactured from glands).
 

Chemical composition is:


HO 0- CH 2CHOOH 
10 NH2 
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Biosynthesis of thyroxine is closely related to


the iodine metabolism of the body and can be


outlined in Figures 26 A and B (after the book


of FRIEDEN and LIPNER (128). Accordingly, i)


TSH exercises a regulatory role on the biosyn­

thesis and secretion of T4 (together with other


thyroid hormone, 3,5,3-triiodothyronine (T3 )),


2) T and T4 are secreted into the plasma from


which they are absorbed to influence the body


metabolism.


According to FRIEDEN and LIPNER (128), the


thyroid hormones regulate the metabolism of most


of the adult bulk tissues - skeletal muscle,


heart, liver, kidney - but do not normally


affect the lungs, lymphatic system, gonads and


accessory organs, nervous tissue, skin, smooth


muscle, or thyroid gland. In physiological


doses, the thyroid hormones have a depressant


effect on the pituitary. In these affected


tissues, T3 and T4 show no fundamental quali­

tative differences in their action, aithough


T3 acts sooner than T4 and its effects are of


shorter duration. This has been explained on


the basis that T3 is bound less firmly to


serum proteins (especially the thyroxine­

binding globulin) and is thus more rapidly


released to tissues than is T4. The metabolic


effects of T4 and T3 are therefore referred to


as interchangeable. Though-the thyroid hormones


have a distinct chemical structure, they induce


numerous effects that may ultimately be initiated


by a mechanism resembling that of other hormones.


In common with growth hormone, insulin, and


adrenal glucocorticoids, the thyroid hormones


have a general stimulatory metabolic effect on


numerous tissues in the vertebrates.


There is a striking synergism between T4 and GH.


Pituitary function seems to be dependent on a
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minimal secretion of thyroid hormone, an amount


insufficient to produce a detectable effect


on the oxygen consumption of an animal. In


the absence of thyroid hormone, GH can stimulate


many of the aspects of normal growth, but,


adequate T4 enhances the overall rate of growth.


The thyroid hormone seems to be exclusively


involved in the maturation of certain tissues


- particularly brain,,bone, and skin.


Regarding the underlying mechanism involved,


an independent stimulatory effect was found


of both T4 and GH on liver RNA polymerases.


The experimental data emphasize the "permissive".


effect of thyroid hormone on growth. The hormone


permits normal growth and maturation; when absent,


inadequate development occurs. However, it will


not stimulate growth beyond the normal level,


in contrast to GH. Although there is an upper


limit in the growth response to thyroid hormone,


excessive doses can produce an exaggerated effect


on catabolic and oxidative metabolism with a
 

large increase in oxygen consumption, a negative
 

nitrogen balance, and a loss of weight. This is


considered-a thyrotoxic effect, distinct from


the normal response. Thyroid hormones are


contributors to the maintenance of the body


temperature of homeotherms.


Calorigenesis does not account for all the effects


of thyroid hormones in restoring the hypo­

thyroid adult to the normal (euthyroid) state.


A more basic mechanism appears to be involved


in the T4 stimulation of RNA polymerase acti­

vity of liver nuclei from thyroidectomized rats.


The rate of cytoplasmic protein synthesis is


also reported to be increased by a thyroid­

hormone-induced mitochondrial factor. Greater


oxygen utilization may be viewed as the result,


rather than the cause, of these metabolic events.


Accordingly, thyroxine is used for therapy


in the following cases (128, 129):


- acute nonsupporative thyroiditis,


- atherosclerosis,


- cretinism,


- goiter due to hypoiodinism,


- Hashimoto's disease, 

- myxedema,


- ovarian disease,

- spontaneous hypopituitarism,

- threatened abortion,
 
- thyroid carcinoma,

- thyroid disease.

Beyond this broad application, the-scientific


research areas can be identified as follows:


- interactive effect of T4 with other hormones, 
- calorigenic effect (reducing feeling of cold). 
Examples given above are, though far from
 

complete, clearly indicate, 1) the broad range


of applicability of hormones in the medical


field, 2) the potential in scientific research


which has not been exploited yet, and 3) the


commercial possibilities if these compounds could


be produced inexpensively and in large quantities.


It is noted, that T4 was found to be less soluble


in aqueous solutions. Therefore, caution must


be exercised in selection of this substance as


a first candidate for Space Bioprocessing experi­

ments. It is recommended to select this hormone


as a secondary candidate if the difficulties


in separation-recovery technology can be


overcome bysuitable experimental technique.


7, EQUIPMENT DESIGN FOR SPACE BIOPROCESSING


7.1. GENERAL OBSERVATIONS


One of the objectives of this study is the identi­

fication of an equipment which has the capability


to perform bioprocessing under space conditions.


In particular, the equipment will serve the purpose


of carrying out bioreactions performed by intact


living cells or their constituents (e.g. enzymes)


resulting in compounds of interest which, then


undergo recovery-purification processes. According


to the objectives, the equipment in question is


considered as a prototype. Its performance will


enable the users to modify'and scale it up to meet


future technical needs.


Living. cells cultured in vitro need adequate


environmental conditions to express their maximum


metabolic activity. This rule also applies to the


biochemical or chemical reactions.


Also, during the implementation of biological or


chemical reactions, it is desirable to know the


status of the process. This serves the following


purposes: 1) analysis of process performance and,


on this basis, 2) adjustment of necessary environ­

mental conditions.


In order to cope with these constraints, the fermen­

tation industry gradually accumulated knowledge


related to the engineering and process aspects of


application of cells and enzymes in bioconversion


of organic materials. In addition, techniques were


developed to recover and purify the biosynthetised


compounds. Experiences obtained in -hese areas


are covered by a discipline called biochemical


engineering (6).. This discipline deals with the
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theoretical and technical aspects of unit and 'systems


operations related to culturing living cells or their


subcellular elements under controlled environmental


conditions.


According to experience accumulated in biochemical


engineering, the following main rules must be observed


in designing bioprocessing hardware:


1. 	 Systems Integrity. Bioprocessing equipment as
 

a system consists of three major elements: 1)


Biosynthesis equipment, 2) Recovery equipment,
 

and 3) Process support subsystem. From an


operation point of view, all those elements are


considered as one unit. -This principle defines,


the type and number of monitoring and control


elements as well as the mode of operation of


the system.


2. 	 Systems Flexibility. In fermentation practice,
 

a properly designed bioreactor can perform


more than one type of biosynthesis (e.g. a


fermentor designed for penicillin-G biosynthesis


ban be used to produce oxytetracycline. Only


the species of microorganism and the culture


medium composition change). Recovery equipment
 

and technology, however, are dependent on the


chemical structure of the compound. Therefore,


they vary from process to process.


In the particular case of the space bioprocessing


system, the following constraints were considered:


1) 	 The system serves the purpose of proving or


disproving the advantages of bioprocessing


in space.


2) 	 In the case of positive-results, the system
 

must be capable to perform more than one type


of biosynthetic activity, the result of which
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will be recovered by one technique: electro­

phoresis. At the beginning of the experiments,


particularly in the test stages, at least


three types of reactions can be visualized:


1) Fast, chemical and/or enzymatic con­

version of compound A into B (where compound


B is the subject of recovery), 2) Relatively


fast microbiological process (doubling time


; 20-60 minutes, product formation rate


(dP/dt) < 5G/L/HR and 3), Relatively slow


process (doubling time = 10-20 hours, product


formation rate (dP/dt) > 5G/L/HR).


Accordingly, the internal design and instru­

mentation of the biosynthesis subsystem


must allow sufficient flexibility to make


the implementation of enzymatic


reactions, microbial fermentations,and


animal cell suspension cultures possible;


It is necessary to note that in all cases,


the 	recovery subsystem (EFO).is unchanged.


This makes the application of a "buffer


subsystem" necessary. This system couples


or uncouples the biosynthesis and. recovery


subsystems depending on the differences


between the kinetics of biosynthesis and


recovery.


3. 	 Control of environmental conditions. Fermentation


practice revealed the importance to set and


maintain optimum environmental conditions which


assure the maximum cellular or enzymatic func­

tions. Factors instrumental to set the proper


environmental conditions include: temperature


(T), gas pressure (P), liquid pH, substrate


and product concentrations. Among the substrates


the carbohydrates, oxygen, nitrogen, phosphorus,


certain ions (e.g. mono and divalent cations)
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as well as bios materials (e.g. vitamins, hormones)
 

are of importance. Among the products are the


target product itself and its byproducts. Specific


care must be exercised in removal of unwanted


byproducts, particularly C02 which was shown


to have influence on cellular activities (79).


The 	 control of environmental conditions is gen­

erally performed via conventional control


instrumentation composed of a sensing element,


an amplifier (+ signal conditioner), comparator


system, and an actuator which performs the necessary


control function(s). Because of the difference


in control functions, the apparatus required for


control of process variables will differ signifi­

-cantly (Table XVIII). A brief analysis of this


table reveals that considering the physico-chenical­

conditions existing in Space, many of the conventional


manipulated variables cannot be applied in the
 

operation of a space biosynthesis system. This


is particularly valid for motor-shaft driven


mixers and equipment.for removal of unwanted


metabolic byproducts. On the other hand, because


of reportedly successful operations of pumps in


zero - G, these mechanical systems can be considered


for moving liquids and gases (17).


4. 	 Automatic operation. Because of the anticipated


workload aboard the Spacelab, the equipment must


contain extensive electronic monitoring, process


analysis and control equipment which reduces


the necessity for scientists to manually operate


the system. In addition, and more importantly,


the prerequisite for proper evaluation of test


experiments is the acquisition, analysis and


logging of experimental data. This question


will be discussed in detail in the subsequent


sections.


TABLE XVIII


CONTROL SYSTEMS GENERALLY USED INBIOCHEMICAL ENGINEERING


MEASURED MANIPULATED INTERMEDIATES CONTROLLED 
ESEMATED VARIABLES VARABLES 
VARIABLES 
TEMPERATURE 	 COOLANT FLOW 
 TEMPERATURE 
 
VALVE POSITION 
 
LIQUID FLOW RATE 
 PUMP MOTOR SPEED SWITCH PUMP MOTOR SPEED 
 
GASFLOW RATE GASFLOW VALVE 
 GAS INPUT INTO 
 
POSITION THE LIQUID


VESSEL PRESSURE 	 EXHAUST GAS VALVE VESSEL HEAD 
 
POSITION PRESSURE


DISSOLVED OXYGEN 	 MOTOR SPEEDj 	 KLA 
 P02 
 
LEVEL GASFLOW VALVE 
 
PRESSURE REGULATOR


PH 	 REAGENT FLOW 	 He/OH -

NUTRIENT CONCN, 	 PUMP SPEED REAGENT CONCENT-
 S 
 
RATION


PRODUCT CONCN, 	 PUMP SPEED P PN 
 
DISTURBANCE


METABOLIC + MIXING


HEAT


BROTH VISCOSITY


VESSEL HEADPRESSURE


GASFLOW RATE


TEMPERATURE


PRESSURE, KLA


OVERDOSE OF REAGENT


METABOLIC PRODUCTS


OVERDOSE (S)


INCREASED RATE


OF P FORMATION
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7.2. OUTLINE OF EXPERIMENTS 
In order to obtain statistically acceptable experi­

mental results which demonstrate the direct or
 

indirect effects of microgravity on (micro)-bio­

logical processes it is necessary to perform


experiments simultaneously in 1-G and O-G condition


Figure 27 presents the outline of the experiments.


Four stages are considered, namely:


1. 	 STAGE 1. Ground based experiments with the


first prototype of the Basic Bioreactor System


as well as other currently available equipment
 

to develop the experimental methods and the


analytical techniques to follow the course of


the reactions. In this state it is essential


to determine correlations between the wet


chemical analytical data and the changes in


signals originated from sensors which are the


part of the Space Bioreactor System." This,


approach was successfully applied in definition


of correlations between nucleic acid, protein,


product biosynthesis (determined with complex


wet chemical analytical techniques) and the


changes in.dissolved oxygen concentration,
 

oxygen uptake; C02 release rates as well as


ii respiratory quotient (all measurable or


computable by means of direct reading sensors)


(21). 
In case of the proposed model reaction corre­

lations between the progress of the reaction


and changes in pH, or DO are easily defined.


Considering, however, the complex assay tech­

niques relative to hormone determinations


(e.g. complement fixation, radio-immunoassay,


etc.) the search'for correlations is an absolut(


necessity for future automated operations in


OrG 	 conditions.


FIGURE 27 

OUTLINE OF EXPERIMENTS IN1-G AND O-G CONDITIONS 
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Stage 1 experiments also include individual


coordinated works in product separation and


purification techniques.


Minimum success criteria in this stage of the


project are:


1) Development of the model reactions­

(methodology),


2) 	 Development oftthe correlations between


the chemical changes and the direct reading


sensorial outputs; statistical analysis


techniques,


3) 	 Development of (at least one) hormone pro­

duction technology including the cell


culture technique, the analytical methods,
 

and correlations between wet chemical


analytical data (reflecting the cell


physiology-product formation) and the


changes of direct reading sensorial signals


as well as recovery technology. (This


part of the project can be extended to


Stage 2).


4) 	 Development of one working prototype of


the Basic Bioreactor System in which a)


Model reactions can be implemented under


1-G condition; b) Hormone production studies


can be started.


2. 	 STAGE 2. Sounding Rocket Experiments with


model reaction performed in the Space


Bioreactor. Parallel experiments are run


in 1-G condition and the previously deter­

mined signals reflecting the process status


are introduced into a ground based computer


which performs the statistical analysis of


data obtained from the:concurrent 1-G and


,O-G experiments.
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Minimum success criteria are:


1) 	 Definition of the operating characteristics


and final design of a Space Bioreactor


prototype. (Making the necessary modifi­

cations and experimental retesting of


designs completed).


In this stage of the project ground based


hormone production and product recovery­

purification techniques are continued.


3. 	 STAGE 3. Space Shuttle Based Experiments.


In this stage, model reaction kinetic studies


will besrun incorporating chemical reactions


(if necessary), enzymatic reactions, however,


the first 1-3 days microbiological model


reaction kinetics will be the main area of


interest. Also, the first product recovery­

purification technology trial will be implementet


jointly or separately from the Space Bioreactor


operation.. An experimental trial for tissue


cultures in O-G may be possible depending on
 

the development of this technology in the first


two stages of the project.


In all cases simultaneous experimental runs


will be implemented comparing the 1-G and.


O-G data by means of on-line, real time


(ground based) computer operation


Minimum success criteria are:


1) 	 Definition of differences between model


cell growth and product formation kinetics


which ultimately defines the effects of


O-G on cellular metabolic activities.


2) 	 Definition of the efficacy of the peptide­

protein recovery, purification technique


in O-G.
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3) 	 Definition of the necessity of further


prototype modification, scale-up criteria.
 

4) 	 Development of the control strategies


necessary to implement fully automated,


coordinated operation of the Space Bio­

processing Equipment (Space Bioreactor +


Recovery-Purification System + Auxiliary
 

Equipment).


4. 	 STAGE 4. Spacelab Based Experiments.


Simultaneous operation of the Space Bio­

processing Equipment in 1-G and O-G conditions.


Anticipated duration is up to one month per


run 	 (for hormone (peptide-protein production)),


1-6 days (for biochemical, microbiological


experiments), 1-24 hours (for chemical


synthesis experiments).


It is emphasized that implementation of this


stage of the project depends on the'advantages


revealed in Stage 3. Also, in Stage 4 wet­

chemical analytical experiments can be performed


as well as on-board computer based process


analysis and process control can be implemented.


The 	 information obtained by this means provides


the engineering data for construction of the first,full'


automated pilot-plant for space bioprocessing


purposes.


7.3, iBs_ BIOnACToR sin 
7.3,1, GENERAL 
In view of the previous constraints, a Basic Space
 

Bioreactor System (SBI) is identified as a prototype
 

equipment with the capability of:


1. 	 Performing organic chemical, biochemical reactions


as well as serving as culture vessel for culturing
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a) microbial cells, b) animal tissues and c)


animal cells in suspension. This system will


be used for 1-G and O-G experiments with the


premise that it goes through modifications


subject to experiences with the equipment,


performance as well as developments and findings


of new model reactions and cell culture techniques-.


2. 	 Monitoring essential process variables such as


T, P, pH, dissolved oxygen concentration (DO),


oxidation-reduction potential (ORP). Also,


liquid flow rate, flow rate of reagents and


gases are known as predetermined values. In


addition, provision for sampling wet-chemical


analysis is included. Provision is made to


perform gas analysis using a gaschromatdgraph
 

or (in later stages of operation) mass-spectroneter.


3. Controlling essential environmental factors


including, at least, T, P, substrate(s) input


and product-byproduct removal.


4. 	 Acquiring and transmitting signals related to


the process status either to a multi-channel


recorder or (by telemetry) to a computer for


data analysis.


5. 	 Discharging culture medium to product recovery.


The conceptual design of this multipurpose (convertible)


Basic Bioreactor System (SBI) is shown in Figure 28.


7.3.2. RATIONALE OF THE BIOREACTOR DESIGN


Under terrestrial conditions, bioreactors are-gen­

erally sterilized with steam (6). Moreover, in order
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to assure sterility during the process, steam is


constantly supplied to the bearing house through


which an agitator shaft is introduced into the


culture vessel.. Production of steam in a Spacelab


would require unnecessary payload. Therefore, the


conventional "fermentor" arrangement, (having


shaft driven mixers), was rejected and a tubular


loop bioreactor design was selected, instead


(131). Operational characteristics of this


model were investigated recently (132). According


to experimental data (132), the system behaved


similarly to a conventional stirred tank reactor


and was scaleable from a bench model to pilot­

plant scale. In particular, the fluid circulation


was found simpler, the oxygen transfer was suffi­

cient to support vigorously.growing S. cerevisiae


and C. tropicalis (on n-hexadecane) cultures, and


practically all the above mentioned, process and


control variables were measurable and controllable.


An additional feature of this design is the possi­

bility to apply dialysis systems (22) considered


essential for removal of unwanted byproducts (e.g.


C02). Moreover, such system can be sterilized


using ethyleneoxide -CO2 mixtures instead of. steam.


However, direct steam sterilization (for terrestrial


-experiments) is also possible.


The equipment can-also be used as a chemical or


biochemical reactor as well as a culture vessel


assuring growth both for animal tissues or cells


in suspension.


The only moving part of such a system is a set of


pumps which significantly reduces the risk of


mechanical failure during operation and creates


less shear than a conventional mixing apparatus


equipped with agitation blades.


1 
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7,3.3, ELEMENTS OF BASIC BIOREACTOR SYSTEM 
According to Figure 28, the Basic Bioreactor System


has the following major elements:


REACTION CHAMBER (RC) with inldt and outlet parts


-(estimated total volume: up to 500 cm3 , estimated


working volume up to 375 cm3). In case of


Sounding Rocket experiments, RC total volume


does not exceed 100 Cm3.


2 'PIPE (PE) with diameter to allow liquid circulation


with a velocity up to 2-3 m/sec. Various quick­

.fit disconnect port locations are welded into


the pipe. Material: 316 SS.


3 	PUMP (PU) connected to Pipe 2 assuring the culture


liquid circulation with a speed up to 500 cm
3/
 
min. Pump is steam and/or ethyleneoxide steri­

lizable.


4 	 HEAT EXCHANGER (HE) with the capacity to remove


about 1,000 kcal/hour heat (regulated by T con­

troller),


5 	 REAGENT VESSELS (RV) directly connected with


Reaction Chamber 1. Type and size of vessel


will vary depending on the task they are involved


in. Generally., RV has the following design


characteristics:


1. 	 Inlet/outlet ports regulated by electronic


or manually operated valves,


2. 	 Quickfit connection with RC,


3. 	 Liquid transfer is performed by gas (N2) pressure
 

4. 	 Sterilization either by ethyleneoxide - CO2


gas mixture or by steam.


5. 	 Working capacity varies from 10 cm3 to 100 cm3 .
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.6 AIR/GAS INTRODUCTION SYSTEM (AG) consisting of: 
1) 
2) 
3) 
4) 
connections to the liquid circulating pipe, 
pressure controller with P signal, activated 
or manually operated valves; 
gas filter (F) of 0..22 p particle retention, and 
gas cylinders connected to the filter. 
7 DIALYSIS UNIT (DU) connected to Pipe which en­
,ables removal of products.­
8 INSTRUMENTATION SYSTEM (IS) consists of a number 
of subsystems. These are listed -in Table XIX 
along with their specifications for the sensors, 
measuring and controlling accuracy as well as 
the data logging capabilities. 
Function of the Instrumentation System is:


1) 	 Maintenance of the necessary environmental con­

ditions with specific respect to temperature


and pressure control,


2) 	 Follow the physico-chemical and chemical changes


reflecting the reactions performed in RC. This


applies to changes in pH, DO, ORP, GC/MS and


wet-chemical analysis (WCA).


Vendors for each individual subsystem will be specified


during the design of prototype for manufacturing.


Process Variable Control. In the first prototype


three,controls, namely temperature of the culture


liquid, the pressureand liquid circulation rate


are 	 essential.


Temperature control is performed by a thermometer


regulated heat-exchanger (HE) with a required


accuracy of ±0.250 C during the reactions.


Pressure is controlled by means of a pressure con­

troller using the pressure transducer's signal.


TABLE XIX


SPECIFICATIONS OF THE INSTRUMENTATION SYSTEM ELEMENTS


IROCESS 
 
/ARIABLE 
 
J) TEMPERATURE 
 
:2) PRESSURE 
 
:3) DO 
 
4) PH 
 
5) ORP 
 
6)VOLATILE 
 
COMPOUNDS 
 
7) SUBSTRATES 
 
PRODUCTS 
 
SENSOR 
 
THERMISTOR 
 
P TRANSDUCER 
 
GALVANIC 
 
DO PROBE 
 
GLASS, 
 
COMBINED 
 
GLASS, 
 
COMBINED 
 
GC/MS 
 
SPECTROPHOTO-

METER 
 
LEGEND: TE TELEMETRY; CI = COMPUTER INTERFACE; CO = CONTROLLER; R CHART RECORDER


RANGE 
 
+5-+1300c 
 
1-2 ATM 
 
1-100% 
 
OF DO 
 
2-10PH 
 
'±500mV 
 
ACCURACY 
 
0.25°c 
 
'0.1 ATM 
 
±1% 
 
±0.1 PH 
 
±5MV 
 
SIGNAL 
 
OUTPUT 
 
4-2OMA 
 
0-100MV


4-2OMA 
 
0-100MV


4-2OMA 
 
0-100MV 
 
4-20MA 
 
0-100MV


4-2OMA 
 
±0-100MV


4-2OMA 
 
4-2OMA 
 
SIGNAL


INTRODUCED 
 
TECICOR 
 
TE,CIj(CO),R 
 
TE,CIjR 
 
TECIR 
 
TE,CIR


(TE,CI),R 
 
(TECI),R 
 
NOTES


HE CONTROL


CO (OPTIONAL)


CO (OPTIONAL)-

VALVE ACTUATION


VALVE ACTUATION


FUTURE APPLICA-

TION


GROUND APPLICA-

TION
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The controller regulates the air/gas introduction


valves. The principle of operation is shown in


Figure 29. Mixtures of N2/0 2/C02 gases are introduced


at a specified rate from gas cylinders (6A, 6B)


through a filter. For reagent addition by pressuri­

zation with N2, the rate of N2 gas introduction from


cylinder 6B proportionally decreases to compensate


for pressure changes in the system. The flow valve,


which regulates the specific flow rates of gases,


can be regulated manually or by a control signal


originated from a dissolved oxygen controller.


Liquid circulation rate is adjusted manually using


a switch on the circulating pump. Start of the


pump is actuated by ground based signal (Stage 2).


pH is controlled by addition of fresh nutrients


or using buffer systems in the early stages of the


project. Optimum temperature, gas flow rate, and


liquid circulation rates for Stage 2 experiments


will be defined by ground based experiments (in


Stage 1).


Physical connections between the system elements.


Connections between RVs, PE sensors as well as AG


gas cylinders will be made by means of quickfit


disconnects. This type of connection provides


airtight (aseptic) operational characteristics for


a complex animal cell suspension culture systems


(98) and give flexibility to the system usage.


Type "A" connections are Swagelok QM series quick


connects (Figure 30A). Part XI is welded onto


the RC's wall, part X2 is connected to the pipe


attached to the Reagent Vessel. This mechanism


makes it possible to attach any type of RV to the


Reaction Chamber as well as change RV upon demand.


Type "B" connections (Figure 30B) work on the basis


of similar principle as Type "A" connections.
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FIGURE 30


QUICKFIT CONNECTIONS OF SYSTEM ELEMENTS
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They make it'possible to interchange different type


Reagent Vessels and dialysis units with the liquid


circulation pipe. They also serve the purpose of


attaching gas cylinders to the liquid circulating


pipe. In this case, however, the connection is


manually secured.


Type "C" connection .(Figure 31) serves the purpose


to hold sensors inserted into the Reaction Chamber.


Anticipated bore size is 31 mm which, in principle,


defines the outer,diameter of the sensor. This


technical approach makes it possible to interchange


sensors (e.g. interchange ORP probe with pCO2


sensor). Note, a provisional, Type "C" connection


in order to assure insertion of new sensor elements
 

to the Reaction Chamber.


Interchangeability of Reactor Chambers. The quick­

fit type connections qffer an unique opportunity to


interchange system elements. In particular, re­

placing Reaction Chambers is of importance. Currently,


three major types of RC are envisioned, namely:


1) 	 316 SS RC (RCl) which serves the purpose of


conducting organic chemical, enzymatically
 

catalysed reaction as well as culturing of


freely suspended cells (e.g. bacteria or


animal cells-which grow in suspension) .


2) 	 Titanium RC (RC2) which offers an opportunity


to grow animal cells in mono-or multilayer


(perfusion culture). In this case, one or more


Reagent Vessel carries the necessary culture


medium prepared and sterilized under terrestrial
 

condition and introduced into the Reaction-

Chamber by pressure.


3) 	 Capillary Chamber (RC3) made of 316 SS or suitable


plastic material. This serves the purpose of


139 
SENSOR


FIGURE 31


ATTACHMENT OF SENSORS TO THE REACTION CHAMBER 
140


supporting growth of animal cells on micro­

capillaries. Nutrients are introduced in a


manner similar to that described in point 2) above.


With this configuration, essentially all possibilities


for reactions and bioprocesses referred for the


studies mentioned in Chapters 5 and 6 can be implemented


both under terrestrial and microgravity conditions.


7.3.4. PROCESS STATUS ANALYSIS AND LOGGING SUBSYSTEMS


Based on the experimental design for the project, the


following hardware is-necessary to monitor the process


status, acquire and transmit signals, and for processing


and logging of data:


i. Sensors inserted into the Reaction Chambers,


2. 	 Wet-Chemical Analytical Equipment (spectrophoto­

'meter, gaschromatograph, mass-spectrometer),
 

3. 	 Amplifiers and Signal Conditioners,


4. 	 Telemetry signal transmission system,


5. Computer Interface,


6. Computer and peripherals-,


7. 	 Multichannel Recorders (analog ordigital).


Figure'32 presents a schematics of the hardware con­

figuration required for the Sounding Rocket, Space


Shuttle and Spacelab as well as the ground based


experiments. It is noted that the process analysis


and data logging hardware remains the same for the


1-G experiments, whereas the requirement for hardware


increases with the progress of O-G based experiments.


Pilot-plant version of the Space Bioprocessing System


will require a different interface and process controllet


design.


Sensors-Amplifiers. According to the Instrumentation


System specifications (p.. 132 and Table XIX) all of
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the direct reading sensors are inserted into the


Reaction Chamber(s) and the signal is amplified as


well as conditioned to result in a 4-20 mA analog


signal, proportional to the measurement range of


the particular variable. These signals are intro­

duced either to a Telemetry Subsystem and/or to a


Computer Interface-Computer System for further


data processing and logging.


-Wet-Chemical Analysis System. A provision is assured


to connect a GC/MS to the Reaction Chamber either


for on-line, real time measurement of compounds of


low molecular weight (such as N2, 02, H20 (vapour),


or compounds of MW 100 ). The provision houses


a septum for a syringe or an automatic sampler


for collection of sample from the reactor "headspace".


Data are sent either to a Telemetry System (Stages


3 and 4) or directly into a computer interface and/or


are recorded. An additional sampling port is provided


to take samples for spectrophotometer based wet-chemical


analysis. Similar to GC/MS based analysis, this is


performed during all terrestrial experiments and


serves the purpose of finding the needed correlations


between the assays and the on-line reading signal


changes indicating the progress of the reaction.


Telemetry Subsystem. Provided by NASA as part of


the Sounding Rocket, Space Shuttle and Spacelab.


For the Sounding Rocket and Space Shuttle tests the


following channels are required:


- seven analog channels for terrestrial receiving 
stations for T, P, pH, DO, ORP and two optional 
channels (maximum), 
- six contact closure channels (digital) to actuate 
pump (on/off), three RV valves, one gas/air 
valve plus one optional valve (maximum). 
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For the Spacelab tests an electronic module containing


the actuators for pump and valve operations will


be designed. Telemetry System performs the trans­

mission of directly acquired and computer processed


signals to the terrestrial receiving station.
 

Computer Interface, Computer Peripherals. -

1-G System contains:


-
 Telemetry Receiving - Computer Interface Subsystem,


- Direct interface with 1-G Reactor Chamber sensors 
having an identical number of.analog channels with


those used for the Sounding Rocket, Space Shuttle--

Spacelab Reactor Chambers,


Digital Computer with minimum 64K (16-bit word


length) core memory (processing time: 900 nsec),


two 1.2 million (16-bit word length) disks


(drivers and controllers), tape recorder with


about 1.0 million (16-bit word length) capacity,


teletype (TTY) to introduce off-line information


(e-.g. GC/MS data) into the computer.


OG System (for Spacelab only; optional for Space


Shuttle) contains essentially the same capability


as specified for 1-G system. Interface channel


number will be augmented, however, if interactive


control for the pilot-plant scale Space Bioprocessing


System is developed.


Multichannel Recorder(s). Essential for recording


of all acquired process variables (including GC/MS


data) regardless they are obtained from 1-G or


O-G experiments. Multichannel recorder (9 channels)


per Reactor unit is used during all terrestrial


experiments and for the case of the Spacelab experiments


Computer Software. - is based on -FORTRAN IV or


equivalent scientific language for processing
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statistical information. The specific programs


include:


1. Real-Time Executive,
 

2. Data Acquisition (on-line or with TTY),


3. Noise Filtering,


4. Statistical Analysis,
 

5. Signal Transmission,


6. Data Logging and Retrieval, as well as


7. Data Plotting Subprograms.


In a later developed form (for Spacelab operation),


the program will incorporate a control subprogram


which is based on the process status and governs


the coordinated operation of the bioreactor and


recovery-purification as well as the auxiliary


subsystems (see page 146).


7,3,5, INTEGRATION OF SB-l WITH RECOVERY APPARATUS


Figure 33 presents a schematic for interconnection


of the bioreactor and recovery apparatus. The


final recovery-purification unit is an electro­

phoretic apparatus (EFO). Samples for recovery


can be obtained via dialysis system 7 or directly


from the liquid circulation pipeline 2. The dialysis


system supplies a cell-free liquid containing a


relatively low product concentration. A direct sample


system provides the culture liquid containing all


of its constituents. Because of the anticipated


differences in the kinetics of biosynthesis, and product


separation and purification,a "buffer subsystem"


9 is placed within SB-i. In this case the buffer


subsystem collects culture liquid during the recovety­

purification operation. Discharging culture liquid


onto the EFO system is regulated by the progress


of the recovery-purification step. It is necessary


to develop a sensorial system with a capability
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to detect the status of the recovery-purification


process performed by the EFO apparatus. This


provides control signals which operate the valves


discharging samples into the "buffer subsystem"


and into the EFO apparatus. The necessary sensorial


system which identifies the status of recovery­

purification process is not defined at this time.


Buffer subsystem vessel 9 is made of 316 SS and


has connection previously described in Chapter


7.3.3. (p. 132 and Figures 30-31). The subsystem


can be modified to serve as an ultrafiltration


apparatus to concentrate the target compound prior


to purification.


7,3,6, COORDINATED OPERATION OF SUBSYSTEMS


According to the principle of systems integrity


the operation of biosynthesis, recovery and support


subsystems will be coordinated. Figure 34 shows a


concept of the systems operation control. This


assumes identification of the process status both


for the biosynthesis and for the recovery part of


the system. As was shown, the biosynthesis stages


and its kinetics can be analyzed and controlled on­

line, in real time. This part of the process is


considered, however, to be the most complex, exposed


to many unexpected disturbances. In the Case of


product recovery (dialysis and EFO) liquid flow rates
 

and material concentration are considered to be the


pivotal variables.
 

Information on the status of both processes is fed


into the controllers of the process support system.


This assures the proper rates of gas and liquid
 

removal and purification as well as defines the


availability and supply of utilities. It is well


known that the microbiological processes are water


extensive. Therefore, particular care must be exercised


to assure the proper water recycling schedules.
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The task of construction of a system with such a


complexity and the payload constraints require


application of microprocessors for process control


purposes. These are programmed according to


findings while using minicomputers in process


analysis and controls of biosynthesis and recovery


systems during the test stages., The development


of this coordinated function and the necessary


hardware is a subtask to be solved in the second


and third stages of the project and experimentally


tried in the fourth stage in parallel experiments


under 1-G and O-C conditions.


7,37, SPECIFICATIONS 
According to the aforementioned constraints, three


prototypes of the Space Bioprocessing System are


considered, namely:


1) 1-G Experimental Model, consisting of all elements


of the Basic Bioreactor .System (SBI) + On-Line


Instrumentation + EFO Apparatus, interfaced


with an on-line operating minicomputer. This


3
vessel has 500 cm total and 375 cm3 working


capacity and is equipped with provisions to


take samples for wet-chemical analysis.


This 1-GEM,serves the purpose of experimental


definition of the optimal conditions for model


reactions as well as animal cell-culture studies


for production of peptide-protein type compounds


of scientific-medical importance. Dialysis,


buffer-subsystem (ultrafiltration.apparatus) and


EFO are used to define the conditions for product


recovery. This apparatus will be later augmented


to incorporate auxiliary subsystems for byproduct


and waste recovery.


Major specifications of this 1-GEM prototype are


given on Table XX (with the exception of data


acquisition, data processing and logging elec­

tronics as well as the wet-chemical analytical


apparatus).


TABLE XX


PRELIMINARY SPECIFICATIONS FOR SPACE BIOPROCESSING SYSTEM


(FIRST PROTOTYPE)

(MAXIMUM SIZES ) 

SUBSYSTEM DIMENSION WEIGHT POWER SPECIFIC CONDITIONS 

(H/ W / D) (KG) REQ'D
(CM) 	 VA, 

BIOREACTOR 43/45/23 15 500 STERILIZATION WITH ETHYLENE­
(RC, FE, PU,DIARV4 ) OXIDE-CO2 AND/OR STEAM (ON 
THE GROUND) 
PH ANALYZER 
 17/24/17 1 50 
DO ANALYZER 
 17/24/17 1 50 
ORP ANALYZER 
 17/24/17 1 50 
T CONTROLLER 
 10/20/10 2.0 75 
P CONTROLLER 
 10/10/10 0.7 50 
BUFFER SUBSYSTEM 
 10/5/15 1 0 
II EFO APPARATUS 
 C.F. NASA'S A.O. NO. OA-76-02 	 NEEDED FOR I-G CONDITIONS FROM 

THE BEGINNING OF PROJECT AND 

FOR O-G CONDITIONS IN SPACELAB 

(SPACE-SHUTTLE OPTIONAL) 

* REAGENT VESSELS OF 100 CM3 ARE ASSUMED, 
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1-GEM or its modified versions will operate
 

throughout the four stages of the project.


2) 	 Sounding Rocket - Space Shuttle Prototype (SRSSP)


which is a size reduced version of the SB-I part of


1-GEM (RPl = 100 cm3) to meet the space and


payload constraints of the Sounding Rocket (133).


Only minimum electronics is utilized which is


essential to perform model experiments of


relatively short duration in.order to gain


information on the effect of microgravity on


cellular and subcellular activities as well


as experimentally determine the performance character­

istics of the hardware elements (especially T


and P controllers) exposed to launch, orbiting


and return conditions.


The Space Shuttle Prototype version of SRSSP


may be a handcarried model of SBl with an


electronicplug-in capability to the vehicle's


telemetry system.


3) 	 Spacelab Bioprocessing Prototype (-SBP)


A pilot-plant unit can be designed-for the


Spacelab with a working capacity of 10 L.


Equipped with the above described subsystems


for BS-l as well as with on-line process ana­

lyzers and controllers its estimated dimensions


are:


80 cm height, 100 cm width, 60 cm depth with


estimated weight of 120 kg and total energy


requirement of 1.5 KW.


This equipment still can be placed on a work­

bench for convenient operation. Services (air,


N2 , 02, C02 , vacuum, electricity) will be obtained


from Spacelab's supply.
 

In addition to this unit will be the EFO


apparatus. 'Data acquisition, information
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processing logging apparatus as well as any


necessary wet-chemical analytical units are


additional payload constraints.


As an alternative, a modified version of 1-GEM


can be used in the Spacelab. Size and pay­

load constraints (with the exception of com­

puter electronics, peripherals and wet-chemical


analytical apparatus) are estimated in Table 
XX (p. 149). 
In all cases minimum two "identical twin" units


are built; one for 1-G (control) and one for


O-G experiments.


Characteristics of an EFO apparatus are de­

scribed by NASA's Announcement of Opportunity


A.0. No. OA-76-02 (133). This is a continuous
 

flow electrophoresis device, having a 5 mm x
 

5 cm cross section and a high flow rate to


increase the processed volume of experimental


sample. It is anticipated that this model


will go through various modifications in the
 

future. It is noted that only in Space Shuttle


operation (Stage 3) do we visualize an attempt


to operate SBI and EFO together (depending on


the payload possibilities).
 

Telemetry, computer interface, computer peri­

pheral subsystems and multichannel recorders


are not described. It is understood that the


individual vehicles have one or more of these


equipment (133, 134, 135) aboard.


The wet-chemical analytical, GC/MS systems are


not specified. Specs related to these


apparatus can be given only after the evaluation


of the Stage 1 experiments. Also, it is anti­

cipated that commercial GC/MS analytical apparatus


will undergo drastic size and weight reductions


in the next several years.
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7,4 	 EXAMPLE OF EXPERIMENTING THE EFFECT OF MICROGRAVITY


ON BIOCHEMICAL PROCESS


This part of the Report describes an example to


conduct an experiment which attempts 1) to deter­

mine the effect of microgravity conditions on


biochemical process and 2) study the performance


characteristics of the prototype SB-I exposed to


conditions existing during launch, orbiting and


return of the spacecraft.


For the 	 experiment a ballistic Sounding Rocket


flight is used where 5-6 minutes of near weight­

lessness exists during the coasting phase of the


flight (133).


The experiment is conducted in the Stage 2 of
 

Space Bioprocessing project after a) the SB-i


prototype is built and experimentally tried under


terrestrial conditions, b) experimental conditions


are defined for a selected model experiment. These


two factors are considered as technical milestones


in the Space Bioprocessing program achieved in


Stage 1 of the project.


711.1, 	 MODEL EXPERIMENT


For the sake of demonstration of the operation of


SB-I and anticipated results, conversion of D-glucose


into D-gluconic acid by means of glucose oxidase


(c.f. Chapter 5) is selected. The experiment will


be conducted in a working SB-l model using a ballistic


Sounding Rocket during its coasting phase of the


flight.


7,4,2, 	 DESCRIPTION OF THE EXPERIMENT


Two, identical tin, working prototypes of SB-I


(SB-I/i, SB-1/2) equipped with stainless steel
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reaction chamber (RC-l) T, P, pH, DO sensors/


amplifiers, pump, liquid circulation pipe, two


gas cylinders ((02) (N2)) and one reagent addition


vessel will be used. Temperature and pressure in


the reaction chamber will be maintained by con­

trollers. Because of the size constraints for


a Black Brant VC Vehicle, a 40 x 40 cm size model


will be constructed requiring estimated total


0.75 KW for operation. RC-i/I is secured into


its place in the vehicle. In case of necessity,


insulation is applied to compensate wide temperature


changes in the vehicle's compartment. RC-1/2 is


used for simultaneous control experiment under


1-G conditions.


Required telemetry channels for RC-1/1 are: 4


analog channels for (T, P, pH, DO measurement),


three digital channels to actuate pump (ON/OFF),


gas input valve, reagent input valve upon ground


command. -Further, all information related to


compartment temperature, pressure, acoustic,


vibration and longitudinal shock levels as well


as acceleration values are requested by telemetry


as part of the experimental conditions before and


during the flight. All information are introduced


into a ground based computer programmed for on-line,


real time data acquisition, information processing


and statistical evaluation.


Reaction chambers are- filled with specified volume


of aqueous solution of buffer salts and D-glucose,


saturated with oxygen. Strength of the buffer allows


changes in pH, starting concentration of D-glucose


permits the completion of reaction in 5 minutes.


One reagent vessel contains purified glucose oxidase


with a total activity to complete the reaction in


five minutes. These concentration values are deter­

mined in particular stability of glucose oxidase in


aqueous solution for the waiting period before


launching by ground based experiments during Stage 1


of the project. Enzyme solution is sterilized by
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means of filtration using a 0.22 filter and intro­

duced into the presterilized RV pressurized with


N2 , then attached to RC-I by means of quickfit


disconnect.


Reaching the coasting flight condition (determined


by the acceleration value communicated by telemetry)


both models are activated by manual command starting


the liquid circulation, temperature and pressure


controller and introducing the enzyme into the


reaction chamber. It is noted here, that it is


advantageous to set and maintain the T and P con­

ditions before and during the launch phase to avoid


time loss for establishing these environmental


factors during the coasting flight-stabilization


phase of the flight. Operating characteristics of


SB-I must be established in Stage 1 of the project


with specific respect to heat-up temperature stabi­

lization as well as the interactive changes in 02/


N2 gas addition. During the reaction, addition of


02 is terminated and N2 introduction is performed


only to compensate pressure changes due to the


pressurized introduction of enzyme into the reaction


chamber as well as the possible pressure changes


created by .the pump.


Anticipated environmental conditions are: T = 
300 C, P = 1.1 + ATM (preliminary estimates). 
According to the described reaction mechanism of


enzymatic conversion of D-glucose to D-gluconic


acid (see Chapter 5) the reaction can be followed


by the changes in pH and DO level. In Stage 1


the kinetics are defined, the model for l-G


conditions is established and introduced into the


computer as part of the data processing program.


Also, models for deviations are developed con­

sidering uninfluenced, improved or worse kinetic


conditions in microgravity. By comparing the


changes in pH and DO values taking place simul­

taneously during the parallel experiments,
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statistical analysis can be performed to define the


effect of microgravity on the reaction kinetics.


According to Equations /3/15/ and /16/21/, it is


anticipated that changes in D6 level will reflect


S - L conditions, whereas changes in pH will in­

dicate.the L - GA transition. Shape and slopes of


these two different process status indicator curves


will reflect the kinetic constraints from which the


reaction mechanism may also be determined.


In another case we visualize a-DO (or ORP) probe


based kinetic study with varying S and fixed E0


concentration of fixed T and pH conditions (strong


buffer). Analysis of the results is performed on


thebasis of steady-state velocity measurements


where the steady-state turnover data for comparison


can be obtained as tangents to the DO (ORP)


electrode readout and plotted in a double recip­

rocal mode as ET /v versus 1/S or 1/DO unit.


After the reentry and recovery of the vehicle, SB-1/l


is returned for investigations which include:


- physical examination of the hardware, 
- wet-chemical analysis of the reagents (B, S, 
P, intermediate), ­
- rerun of the experiment with the identical 
twin bioreactor. 
It is understood that the Sounding Rocket experiments


are primarily intended to develop experimental tech­

niques, accumulate operational experience, and iden­

tify the effects that the weightlessness imposes on


material conditions and reactions ( 133 ). After


defining and performing the necessary modifications


the Space Bioreactor will be able to serve the purpose


of various bioprocessing experiments with specific


emphasis on biosynthesis (bioconversion) of materials


under microgravity conditions. As it was stated
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previously, we believe, this type of experiment


also enables the users to perform quality control


(performance) tests on newly developed bioprocessing


equipment.


The above described example serves the purpose of


illustrating the type of experiments intended


to perform during the project implementation. It


is anticipated that the Space Shuttle offers extended


time for conducting microbiology oriented experiments


using more sophisticated equipment, whereas. Spacelab


makes experiments possible with animal cells using


pilot-plant type equipment where both biosynthesis


and recovery can be simultaneously tried along-with


application of novel control techniques for the


entire Space Bioprocessing System. Needless to say,


the prerequisite of the Spacelab experiment is a


relentless implementation of ground based experiments
 

which lead to better understanding of animal cell


cultures, biosynthesis characteristics and development


of separation-purification techniques for target


compounds of social-economic significance.


8, CONCLUSIONS AND RECOMMENDATIONS


8,1, CONCLUSIONS


BIOPROCESSING IN SPACE


According to its objectives, this report analyzes


the conditions and possibilities with respect to


bioprocessing of organic materials in Space.


Statements made are based on the observations­

described in Chapters 3-7, and serve the purpose


of an executive summary of our findings.


Bioprocessing of organic materials in Space


covers essentially two major operations, namely:


1). Biosynthesis of organic compounds, and
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2) 	 Recovery of said compounds in microgravity


environment.


Biosynthesis of organic compounds requires an inter­

action of living cells with substrates. The cells


cmn be of microbiological, plant or animal origin,


depending on the type of compound to be produced.


Living cells may be substituted by subcellular


elements (e.g. enzymes). In order to achieve the


potential maximum level of cell-substrate interaction


optimum environmental conditions for the bioreactions


must be established and maintained.


Recovery of the organic compounds from the reaction


mixture (culture liquid) requires complex physical,


physico-chemical or chemical operations. These


result in separation of the target compound(s) from


the contaminating materials. This part.of space


bioprocessing also requires precisely defined techno­

logical conditions.


Implementation of Space Bioprocessing makes it


necessary to design, construct and operate an equin­

ment which has the capability to carry out the


biosynthesis and recovery functions under various


environmental conditions. In the early stage of


the project the equipment is small, however, it has


all the necessary instrumentation for the experi­

mental definition of the optimum operating conditions,


and to analyze the effect of microgravity conditions on


cellular activities. It also has the capability to


be scaled-up to production size should the micro­

gravity environment offer advantages for bioprocessing


organic compounds.


In order to implement the project, a stepwise opera­

tion is needed starting from basic experiments


resulting in better understanding of the effect of


microgravity on cellular or subcellular (enzymatic)


activities, then implementing a manufacturing tech­

nology to produce compounds of social significance.
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1k2. PROBLEMS OF BIOPROCESSING UNDER TERRESTRIAL CONDITIONS
 

According to experience accumulated in the fermentation


industry and in biochemical engineering during the


past 30 years, certain factors are considered as


reaction rate limiting steps for culturing microbial,


plant or animal cells:


1. 	Mass transfer into or from cells. In particular,


the 	 transfer of oxygen from air to the cell wall


(or membrane) and removal of toxic byproducts


(e.g. C02 ) from the culture liquid.


2. Transfer of compounds through membranes. This


is related to all cells and membranes as well


as artificial membranes.
 

3. 	Gravity induced sedimentation of solids, which ­
in the case of cells - reduces the accessability

of substrates to the cell surface. This results


in a tendency of cells a) to float on the surface


of a culture liquid, b) to attach to solid


surface, or c) to settle to the bottom of culture


vessel. In the first two cases, a two-dimensional


growth (i.e. cell arrangement on a surface (cm2 ))


takes place which significantly reduces the product


formation rate as well as the amount of material


produced. In the third case, the lack of oxygen


alters the entire metabolism (aerobic-anaerobic


transition), which may lead to cessation of


biosynthesis of the target compound(s).


Fermentation-industry tried to overcome these diffi­

culties by means of mixing the three (gas-liquid-solid)


phases. As a result, the cells are suspended in


the liquid and a three-dimensional growth (i.e.


distribution of cells in cm 3 ) takes place. This


method has been successful for microbial cell


cultures and significantly increased their productivity.­
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However, animal cells which need attachment to surfE


and 	 are sensitive to shear stresses and surface


tension changes caused by agitation and introductior


of gas bubbles, could only be cultured in


surface cultures (cm2). Although growth in suspensi


cultures of certain ahimal cell lines has been achie


in many cases the cell differentiation might create


problems when attempting to maintain permanent anima


cell cultures for production of organic compounds.


Recovery of compounds from culture liquids under


terrestrial conditions have to overcome gravity
 

induced weight, liquid flow conditions, solid-liquid


as well as liquid-liquid separation problems. These


are 	 generally solved using filtration and/or centri­

fugation techniques.


813. EFFECT OF MICROGRAVITY CONDITIONS ON BIOL 
ACTIVITIES AND MATERIAL HANDLING


The available literature revealed unusual behaviour


of gases and liquids under microgravity conditions.


In particular, the following possibilities are of


interest from the viewpoint of culturing cells or


using subcellular elements for biosynthesis in Space


1L. 	 Enhanced mass transfer by diffusion,


2. 	 Improved membrane permeabilities,


3. 	 Lack of (gravity induced) sedimentation,


4. 	 Lack of gradient density separation of


immiscible gases and liquids.
 

These factors can contribute a) to maintain cells in


suspended form even under mildly agitated conditions


(decreasing the shear stress), b) improve transport


of materials through natural and artificial membrane


These physical effects influence the 02 transfer


and 	 improve the possibility for removal of toxic bypi
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and the target compounds from the culture liquid.


This may enhance metabolic activity resulting in


increased growth and product formation rates.


Suspension type (cm3 ) growth of nondifferentiated


and differentiated cells of animal origin also


may be possible in the absence of gravity induced


sedimentation conditions.


Available experimental data on microbiological,


plant and animal cell growth characteristics under


microgravity conditions revealed some data indicatin
 

the possibility of enhanced metabolic activity


manifested in faster cellular growth of Salmonella


typhimurium (13) and increased respiratory activity


of Spirodella polyrhiza (20). Also, three-dimension


growth of otherwise anchorage dependent animal cells


was observable in altered environmental conditions
 

(101).


With regard to recovery of organic materials from


contaminating compounds under microgravity condition


the electrophoresis technique (EFO) has proven to


be a possible technique. Using EF0 it was possible


to separate living cells under weightless conditions


Specifically, living kidney cells with enhanced


urokinase activity were obtainable from a mixture


of kidney cells. Since EFO is widely used in


preparative biochemistry for separation-purification


of certain organic compounds, this technique could


be utilized as part of bioprocessing procedures unde:


microgravity conditions. Application of such a tech­

nique drastically simplifies the otherwise complex


separation procedures used under gravity induced


terrestrial conditions.


Comparing the experimental data as well as achieve­

ments using microgravity conditions with regard 
to processing inorganic materials in space, our 
current knowledge of the direct or indirect effect


of microgravity on cellular and subcellular activity


is considered to be woefully scarce. Data available
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are either of a qualitative nature or are discounted


because of the lack of establishment of proper


environmental conditions excluding all factors but


the microgravity for influencing the process.


The available data, however, hint at advantages for


space which can not be overlooked if novel bio­

processing technologies are considered ia a modern


society.


.14 DETERMINATION OF EFFECT OF SPACE CONDITIONS ON 
BIOLOGICAL MECHANISMS


In order to obtain unequivocal answer to the question:


"Does the space environment,, especially the microgravity,


exercise direct or indirect effect on cellular mechanism?"


it is essential to design and conduct a series of


experiments using the Space Shuttle and Spacelab oppor­

tunities for this purpose.' A model process was selected


on the basis of Various criteria (p. 15). The process


is the formation of gluconic acid from Drglucose or


from an intermediate (D-glucono-lactone). It can be


performed by organic chemical,.enzymatic means as well


as using fast growing, oxygen requiring microbial cells.


As was demonstrated in Chapter 5, the reaction mechanism


and its kinetics are well known especially in the case


of enzyme facilitated conversion of D-glucose'into


gluconic acid. The glucose oxidase based experiments,


therefore, can serve as starting points to obtain


statistically adequate data which demonstrate the


direct or indirect effect of microgravity on biological


processes.


The ability to perform the D-glucose-gluconic acid


conversion in three different ways offers a unique


opportunity to search out unusual effects of micro­

gravity conditions on reaction mechanisms. In


particular, the transfer df oxygen to the cells and


to the enzyme-substrate complex can be accurately


investigated.
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The reaction kinetics can be followed with direct


reading sensors such as pH and dissolved oxygen


probes. These sensors generate electronic signals


proportional to concentration changes of the


reactants. Signals can be transmitted to the comput


which will be programmed to compare data of simul­

taneously performed experiments in 1-G and micro­

gravity conditions. Data reflect the effect of


microgravity conditions on the reaction mechanism


and its kinetics.


The product of the reactions diffuses through mem­

branes and is recoverable by electrophoresis which i


fact offers an opportunity to test the performance


characteristics of the entire bioprocessing system.


It is also expected that one of the selected


D-glucose-gluconic acid conversion mechanisms can


serve as a quality control procedure to determine


the performance of prototypes or their modified


versions. Also, it serves the experimental basis


for scale-up-studies.


This test experiment is considered as an essential


element in definition of the direct or indirect


effect of microgravity on chemical-and biological


processes. We believe that this type of study is


an inevitable step in the future space-biology


oriented research. Data obtained with this means


will'reveal information of practical importance


relative to the following areas:


1) Space based chemical industry,


2) Space based biochemical-fermentation industry,


3) Biological waste treatment in space colonies,


4) Reactor-control system design for the above


mentioned applications.
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,5, PRODUCTION OF ORGANIC COMPOUNDS IN THE SPACE 
In view of recent and future developments in bio­

chemical engineering, cell culture technology as


well as in the pharmaceutical industry, the following


aspects of space bioprocessing must be considered:


1. 	 There are organic compounds of large social
 

and scientific importance, terrestrial


commercial production technology of which


is-far less developed compared to the oppor­

tunities revealed by scientific and technical


experiments. A study comparing the production


technologies, price structures-of some repre­

sentative compounds (see Chapters 4 and 6)


revealed that the least developed production


techniques as well as the highest unit prices


can be found in the case of peptide type hormones.


Any 	improvement in the production technology


makes a broader application oriented research


and a wider use possible. In addition, improved


technology reduces the price of compounds re­

sulting in less expensive medical treatment.


2. 	 The study revealed that certain peptide type


hormones can be produced by me'ans of in vitro


culturing of animal cells, and recovering them


by means of electrophoretic techniques.


3. 	 Experimental data indicate that the amount of


hormones produced by animal cells is in corre­

lation with the number of cells. Because of


the anchorage dependency, however, hormone


.producing animal cells are generally growing


in two dimension (cm2) (tissue) cultures. This


limits the cell-number and reduces the efficiency


of environmental control operations.


If -. as the qualitative results on cell growth in


space indicate - microgravity enhances the metabolic
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activity and makes three-dimensional cell growth


possible, the hormone production may significantly


increase. A projected maximum hormone secretion


rate at a maximum cell density ( 108 cells/cm3 )


may yield about 2G hormone per liter in 24 hours


(25,26). .Comparing this with the reported yield


of ACTI (12 mg per kg pituitary gland (Table XV))


this is 166 fold increase above the currently


existing output.
 

There are certain technologies developed under


terrestrial conditions which already can increase


the cell number in case of tissue cultures. These


are the capillary cultures as well as the suspension­

perfusion technique. Also, a combination of tissue


and suspension culture seems to be applicable using


microcarriers to support the growth of anchorage


dependent cells. Application of such technologies


with membrane separation of the product and using


electrophoresis for its purification is.considered


a novel technology itself - efficiency of which


ought to be investigated comparing the yields with


those obtained usifig the current hormone manufac­

-turing technologies.


4. 	 Novel techniques developed to culture animal cells


with the capability to product peptide-protein


type hormones and recover them using membrane


filtration as well as electrophoresis can be adapted


to manufacture other peptides and - depending on


the cut-off value of'the isolation membranes - for


proteins in the range of lower molecular weight (50,0(


5. 	 The study detected further advantages in.selection


of hormones as primary target compounds for space


bioprocessing. Mode of action of hormones requires
 

their administration into the body in extremely


low quantities. Therefore, a bioprocessihg unit of


relatively small size can be used for production


purposes, should the early experiments indicate


advantages in enhanced metabolic activity, increased
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growth rate, facilitated membrane separation


and/or electrophoretical purification. Although


the absolute amount of hormones manufactured


in 1974 (our latest available statistical


information) dipped 15 per cent from the amount


produced in 1971, the value of the products


showed a four fold increase. This indicates


a shift in production in the direction of more


valuable hormones (Table XVII) which interests


for improved production technologies.


5. 	 In the past years there has been increasing re­

search devoted to the extrahormonal effects of


certain hormones. In particular, findings that


ACTH can reduce anxiety or improve memory are


of significance. Although these works are in


the early stage and the interactive effects of


hormones (overdose!) can-not be ignored, any


breakthrough requires process technology to
 

manufacture peptide type compounds in substantial


quantity. Cell culture techniques geared to


produce hormones are considered as prime candi­

dates for such an enterprise.


7. 	 Selection of the hormones was based on the


social-need, scientific-medical significance,


availability, production technologies, current


and future production trends and prices (Chapter


6). Accordingly, the following hormones are


recommended for experimental trial for Space
 

Bioprocessing:


- Human Growth Hormone (HGH),


- Human Chorionic Gonadotropin Hormone (HCG),


- Adrenocorticotropic Hormone (ACTH), and


- Thyroxine (T4).


Depending on the funds available, one or more of the


recommended substances can be experimentally tried


for Space bioprocessing. It is noted, however,


that in all cases the necessary equipment must have


the capability to be utilized in microgravi-ty environr
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.1.6. BIOPROCESSING EQUIPMENT 
Regarding the unique material handling conditions


in the Space, the proposed bioprocessing equipment


consists of three major elements, namely:


- Bioreactor,


- Recovery subsystem, and


- Auxiliary equipment.


The bioreactor design is different from the conven­

tional fermentor and tissue culture apparatus used


so far under l-G conditions, however, elements of


the reactor were already successfully tried under


terrestrial conditions. The system is based on a


:ubular loop configuration where the only moving


part is a liquid circulation pump. Interchange­

ability of the system elements makes it possible to


perform chemical, biochemical reactions as well as


culturing microbial, plant or animal cells either


on monolayer or in suspension cultures. Instrumen­

tation provides on-line, real time analysis of the


key process variables such as temperature, pressure,


pH, dissolved oxygen concentration, oxidation-reductio


potential, analysis of substrate concentration and


product formation rates. Construction of several


models seems necessary, one complete bioprocessing


apparatus for terrestrial studies, and other re­

duced size or simplified models in order to cope


with the payload constraints of the various space


vehicles. Depending onthe observations obtained


during the experiments, a prototype up to 10 liter


scale is proposed for extensive study of space bio­

processing techniques during Spacelab flights.


The recovery equipment consists of dialysis/ultra­

filtration membranes and an electrophoretic apparatus.


Experiments with this prototype can be separately


performed (by an other experimental group) parallel
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with the biochemical, cell-culture experiments.


However, it is desirable to operate one 1-G unit


with an integrated capability to perform both


biosynthesis and recovery-purification operations.


Experimental data are transmitted into a mini­

computer for the purpose of statistical analysis


of simultaneous experiments conducted in I-G


(control) and O-G environment. A specific computer


program compares the effects of 1-G and O-G on the


cellular and subcellular activities performed under


specified environmental conditions.


Since the biological processes are sensitive to


gas exchange, care must be exercised to establish


and maintain conditions which influence gas transfers


In particular, precise control of temperature, pressu


and gas introduction are of utmost importance through


the whole project implementation.


.,7. PROJECT IMPLEMENTATION


Four stages of the project.implementation are vis­

ualized. In Stage 1 terrestrial (l-G) experiments


are implemented to define the performance character­

istics of the selected prototype, establish the


optimum experimental conditions for the model experi­

ments and develop technology for the production of


at lease one (peptide) hormone. This part of the


study is continued throughout the implementation of


the whole project.
 

In Stage 2 Sounding Rocket experiments gather data


on the effect of microenvironment on selected model


reaction(s). In this case, experiments of short.


duration (e.g. enzymatically catalyzed conversion


of D-glucose to D-gluconic acid) can be implemented,


however, the statistical analysis will provide enough
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information to see significant differences (if they


exist) in the reaction kinetics as influenced by


1-G and O-G conditions.


In Stage 3 Space Shuttle experiments extend the


scope of investigations using microbial or mammalian


cell cultures for product biosynthesis. Terrestrial


studies on hormone production may make it possible


to perform a relatively short duration hormone bio­

synthesis experiment on early flight opportunities.


Also, (depending on the payload) the first integrated

biosynthesis-EFO experiment can be performed.


In Stage 4 experiments in the Spacelab conclude the


project. These include long duration hormone


biosynthesis, recovery-purification processes


coupled with byproduct (C02) recovery and waste


(H20) recycling operations. Also, fully automatized


operation of the Space Bioprocessing System will be


implemented. The product will be returned to


Earth and used either for scientific or for medical


purposes.


Total anticipated duration of the project is 5+ years.


Scale-up of the successful operation is anticipated


subsequent to the conclusion of this project. However


the information gathered during this period is con­

sidered to be sufficient 1) to define the advantages


of the microgravity on cellular and subcellular .


activities and 2) design (micro) biological or chemica


waste recycling systems for space colonies.


The structure of the project requires ground based


continuous experiments related to the following areas:


1) Definition and statistical analysis of model 
experiment kinetics, 
2) Development of aniinal cell culture based on 
hormone biosynthesis techniques, 
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3) Dialysis, ultrafiltration based recovery of


peptide (protein) type compounds,


4) Electrophoretic purification of peptide


(protein) type compounds,


5) Reactor-subsystem design,


6) Interactive computer control technique


development,


7) Application experiments with peptide (protein)


type hormones.


Each area has to have an orientation and the re­

searchers must have a deep understanding toward


the 	 application of the results in space bioprocessir


,81S 	 POTENTIAL SPINOFFS


In addition to the definition of.effect of space


environment on cellular and subcellular activities


as well as the potential application for production


biological materials in space, the following spinoff


for terrestrial applications are anticipated:


1. 	 Bioreactor vessel sterilization technology


with ethylenoxide,


2. 	 Tubular loop fermentor development (reactor


design),


3. 	 Complex computer control technology for


biological processes (systems, process


dynamics and control),


4. 	 Transport of molecules through membranes


(artificial organ development),


5. -Separation processes and techniques for


peptide-protein type compounds,


6. 	 Waste water treatment.


1,9, SUMMARY OF CONCLUSIONS


Reviewing the studies relative to the potentials in


processing biological materials (19, 103, 130), we
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have a concensus with other researchers that,


1) 	 There is a possibility to achieve better


results processing certain materials in


the Space environment by biological means


if the microgravity enhances the metabolic


activities-and/or improves the recovery


techniques,


2)\. Only compounds of high efficacy or social


importance can be considered as prime can­

didates for first trial. These compounds


must have high production cost, because of


problems in availability of raw material or


complex manufacturing technology,


3) 	 There are compounds which fulfill the criteria


mentioned in point 2) above. In particular,


peptide type hormones are mentioned by us,


vaccines by other researchers. Since both


materials are of peptiderprotein nature,


unique technology developed for the production


of one can be adapted to other. It is noted,


however, that the "amplification" type mode


of action of hormones as well as the most


recent developments in extrahormonal effect


of certain (brain).peptides shift the balance


in faVour of hormones, at least for the first


trial.


4) 	 There is a "vicious circle'! existing relative


to the space bioprocessing: a) no significant


interest is observed from the scientific and


business communities because of the lack of


evidences demonstrating the advantages of the


microgravity environment, b) NASA is reluctant


to push the subject strongly because of the


lack of interest.
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It is our opinion that only NASA can break this


circle by the implementation of the proposed


project. The challenge is given and the advantages


are 	 enormous making positive contributions in


better understanding of biological processes.


8.2. RECOMMENDATIONS


3.2,1. PROJECT OBJECTIVES


It is recommended that NASA institutes a coordinated


Space Bioprocessing Program with the objective to


develop production technologies for biosynthesis,


recovery/purification of biologically active com­

pounds in microgravity.


An additional objective of the project is to obtain


information on cellular and subcellular metabolic


activities as influenced by space environment in


particular, by microgravity. This information can


be used in various fields of applied biological


sciences.


8,2'2, PROJECT IMPLEMENTATION 
It is recommended that the project would be imple­

mented by carrying out a series of experiments in


four major stages under terrestrial and space con­

ditions.


The 	 experiments are divided into three general tasks:


1. 	 Model experiments to unequivocally define the


effect of microgravity on cellular and/or


subcellular metabolic activities,


2. 	 Development of at least one technology to manu­

facture a peptide type hormone of large social


importance with a possibility to reduce the


current manufacturing costs.
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3. 	 Design,. construct and demonstrate


equipment for the above mentioned task


implementation.


All tasks are worked out at first on Earth and


experimentally tried under microgravity conditions


using the opportunities of Sounding Rocket, Space


Shuttle and Spacelab flights.


Tasks are implement6d by a number of specialist team


belonging essentially to four major disciplines:


1) 	 Applied Biochemistry,


2) 	 Cell-Biology - Tissue Culture Techniques,
 

3) 	 Biochemical Engineering,


4) 	 Aerospace Engineering.


A Steering Committee should be organized which review


the 	 development of the tasks and assists-NASA in


organization of the project, recommending priorities,


etc. Members of the committee are recruited from


scientific, engineering and management members of


the 	 following disciplines:


1) 	 Applied Biochemistry,


2) 	 Pharmacology,


3) 	 Cell Biology,


4) 	 Endocrinology,


5) 	 Biochemical Engineering,


6) 	 Aerospace Engineering.


The 	 following centers are recommended for conducting


studies relative to the project or act as members


of the Steering Committee:


.1) Applied Biochemistry


1. 	 Kinetics of Model Systems


Open.
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2. Recovery of Peptides and Proteins (EFO) 
Lehigh University, Sinclair Laboratory #7 
Bethlehem, Pa. 18015 
Dr. HENRY LEIDHEISER, JR. 
2) Pharmacology 
University of Wisconsin Madison 
Center for Health Sciences 
School of Pharmacy 
425 North.Charter Street 
Madison, Wisconsin 53706 
Prof. DAVID PERLMAN 
3) Cell Biology - Tissue-Culture 
W. Alton Jones Cell Science Center 
P.,o. Box 631 
Lake Placid, New York 12946 
Dr. DONALD K. DOUGALL 
4) Endocrinology (Hormone Production), 
Harvard School of Dental Medicine 
Department of Pharmacology 
Harvard Medical School 
Boston, Massachusetts 02115 
Dr. A. H. TASHJIAN, JR. 
5) Biochemical Engineering 
Lehigh University 
Dept. of Chemical Engineering 
Bethlehem, Pa. 18015 
Prof. LEONARD WENZEL 
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6) Aerospace Engineering


Open.


8.2,3. PROJECT PROMOTION 
It is recommended to obtain excellent public relation


for the purpose of project promotion and science


community awareness from the very beginning of the


operation. The following institutions are recommende


to be contacted to arrange seminars, round-table


discussions, paper presentations during the scientifi


business meetings which are regularly done by these


organizations:


(AMERICAN) PHARMACEUTICAL MANUFACTURERS ASSOCIATION


1155 15th Street, N.W., Washington, D.C. 20005


AMERICAN SOCIETY FOR MICROBIOLOGY (ASM)


1913 I Street, N.W., Washington, D.C. 20006


AMERICAN CHEMICAL SOCIETY (ACS)


1155 16th Street, N.W., Washington, D.C. 20036


AMERICAN INSTITUTE OF CHEMICAL ENGINEERS


345 East 47th Street, New York, N.Y. 10017


SOCIETY FOR INDUSTRIAL MICROBIOLOGY (SIM)


3090 Wisconsin Ave., N.W., Washington, D.C. 20016


Results of the research will be published in periodic.


issued by these organizations.
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